Summary

Ranking of Drug—Target Pairs

Rank	CH	MD	DB	KG	Drug	Target	Most Similar Drug		Most Similar Target
1	N	N	Y	Y	Nimodipine	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit	0.75000	Nitrendipine	0.57786	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
2	N	N	N	N	Metoclopramide	CHRNA5: cholinergic receptor, nicotinic, alpha 5 (neuronal)	0.20000	Galantamine hydrobromide	0.44323	CHRNA2
3	Y	N	Y	N	Nicotine	CHRNA4: cholinergic receptor, nicotinic, alpha 4 (neuronal)	0.40909	Phencyclidine hydrochloride	0.52847	CHRNA2
4	N	N	N	N	Proparacaine hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.66667	Procaine hydrochloride	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
5	N	N	N	Y	Benzocaine	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.57895	Procaine hydrochloride	0.60410	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
6	N	Y	N	N	Riluzole	GRIK2: glutamate receptor, ionotropic, kainate 2	0	Kainic acid hydrate	0.81064	GRIK3: glutamate receptor, ionotropic, kainate 3
7	N	N	N	N	Diazoxide	ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9	0.17500	Verapamil	0.68192	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
8	N	N	N	N	Procainamide hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.71429	Procaine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
9	N	N	N	N	Propafenone hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.45714	Disopyramide	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
10	N	N	N	N	Carbachol	CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)	0.35000	Hexamethonium bromide	0.46023	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
11	N	N	Y	Y	Zonisamide	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.36364	Lamotrigine	0.60410	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
12	N	N	N	Y	Gallopamil hydrochloride	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit	0.86486	Verapamil	0.56053	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
13	N	N	N	N	Sevoflurane	GABRR2	0.041667	Propofol	0.68315	GABRR1
14	N	N	N	N	Isradipine	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.73333	Felodipine	0.28502	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
15	N	N	N	N	Carbachol	CHRNA7: cholinergic receptor, nicotinic, alpha 7 (neuronal)	0.35000	Hexamethonium bromide	0.35558	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
16	N	N	N	Y	Diltiazem malate	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.35791	Amlodipine maleate	0.64082	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
17	N	N	N	N	Trifluoperazine hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.87879	Fluphenazine hydrochloride	0.62986	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
18	N	N	N	Y	Diltiazem hydrochloride	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.40425	Nicardipine hydrochloride	0.64082	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
19	N	N	N	N	Haloperidol	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.30303	Ketamine hydrochloride	0.44349	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
20	N	N	N	N	Clozapine	HTR3C	0.37143	Ondansetron hydrochloride hydrate	0.73813	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
21	N	N	N	N	Propofol	GLRA3	0.20690	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
22	N	N	N	N	Mexiletine hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.52381	Lidocaine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
23	N	N	N	N	Procainamide hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.71429	Procaine hydrochloride	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
24	N	N	N	N	Pentobarbital	CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)	0.16129	Metoclopramide	0.46023	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
25	N	N	N	N	Diazepam	GLRA3	0.35484	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
26	N	N	N	N	Sumatriptan	HTR3C	0.28000	Dopamine hydrochloride	0.73813	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
27	N	N	N	N	Paramethadione	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.75000	Trimethadione	0.44753	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
28	N	N	N	N	Pindolol	HTR3C	0.27273	Granisetron hydrochloride	0.73813	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
29	N	N	N	N	Nimodipine	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1	0.75000	Nitrendipine	0.19447	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4
30	N	Y	N	N	Isoflurane	GLRA2: glycine receptor, alpha 2	0.57143	Sevoflurane	0.76918	GLRA1: glycine receptor, alpha 1
31	N	N	Y	Y	Verapamil hydrochloride	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit	0.97059	Verapamil	0.56053	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
32	N	N	N	N	Carbachol	CHRNA5: cholinergic receptor, nicotinic, alpha 5 (neuronal)	0.35000	Hexamethonium bromide	0.44323	CHRNA2
33	Y	N	N	N	Nicotine	CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)	0.40909	Phencyclidine hydrochloride	0.46023	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
34	N	N	N	N	Tocainide hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.68421	Prilocaine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
35	N	N	N	N	Glyclopyramide	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.73913	Tolazamide	0.39373	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
36	N	N	N	N	Gliclazide	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.79167	Tolazamide	0.39373	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
37	N	N	N	N	Trifluoperazine maleate	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.74468	Fluphenazine maleate	0.62986	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
38	N	N	N	N	Verapamil	KCNK2: potassium channel, subfamily K, member 2	0.40909	Dofetilide	0.51272	KCNK10: potassium channel, subfamily K, member 10
39	N	N	N	N	Verapamil	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.12245	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
40	N	N	N	N	Encainide hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.53333	Mepivacaine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
41	N	N	N	N	Verapamil	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.29412	Glyburide	0.68192	ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9
42	N	N	N	N	Encainide hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.53333	Mepivacaine hydrochloride	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
43	N	N	N	N	Halothane	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.66667	Methoxyflurane	0.048992	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
44	N	N	N	N	Moricizine hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.43243	Dyclonine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
45	N	N	N	N	Felbamate	GLRA3	0.25806	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
46	N	N	N	N	Tocainide hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.68421	Prilocaine hydrochloride	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
47	N	N	N	N	Amoxapine	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.55556	Mazindol	0.68182	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
48	N	N	N	N	Nimodipine	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.75000	Nitrendipine	0.28399	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
49	N	N	N	N	Flecainide acetate	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	0.25532	Quinine hydrochloride hydrate	0.66887	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
50	Y	N	Y	N	Nicotine	CHRNA7: cholinergic receptor, nicotinic, alpha 7 (neuronal)	0.40909	Phencyclidine hydrochloride	0.35558	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
51	N	N	N	Y	Gallopamil hydrochloride	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.86486	Verapamil	0.64082	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
52	N	Y	N	N	Isoflurane	GLRB: glycine receptor, beta	0.57143	Sevoflurane	0.38089	GLRA1: glycine receptor, alpha 1
53	N	N	Y	N	Pentobarbital	CHRNA7: cholinergic receptor, nicotinic, alpha 7 (neuronal)	0.16129	Metoclopramide	0.35558	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
54	N	N	N	Y	Granisetron	HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic	0.95833	Granisetron hydrochloride	0.40524	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
55	N	N	N	N	Trimethadione	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.75000	Paramethadione	0.44753	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
56	N	N	N	Y	Metoclopramide	HTR3C	0.28000	Dopamine hydrochloride	0.73813	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
57	N	N	N	N	Fluphenazine maleate	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.74468	Trifluoperazine maleate	0.62986	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
58	N	N	N	N	Fluphenazine hydrochloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.87879	Trifluoperazine hydrochloride	0.62986	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
59	N	N	N	N	Caffeine	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.93333	Caffeine hydrate	0.014488	P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6
60	N	N	N	N	Acetohexamide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.72000	Tolazamide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
61	N	N	N	N	Verapamil	KCNK12: potassium channel, subfamily K, member 12	0.052632	Halothane	0.61540	KCNK13: potassium channel, subfamily K, member 13
62	N	N	N	N	Sevoflurane	GLRA3	0.030303	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
63	N	N	N	N	Pentobarbital	CHRNA5: cholinergic receptor, nicotinic, alpha 5 (neuronal)	0.16000	Mecamylamine hydrochloride	0.44323	CHRNA2
64	N	N	N	N	Diazoxide	KCNK2: potassium channel, subfamily K, member 2	0.22857	Dofetilide	0.51272	KCNK10: potassium channel, subfamily K, member 10
65	N	N	N	N	Amiloride hydrochloride	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.14286	Zonisamide	0.47136	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
66	N	N	Y	N	Trimipramine	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.35484	Mazindol	0.68182	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
67	N	N	N	N	Flecainide acetate	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.38461	Dyclonine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
68	N	N	N	Y	Dantrolene	RYR3: ryanodine receptor 3	0.31250	Phenytoin	0.66763	RYR1: ryanodine receptor 1 (skeletal)
69	N	N	N	Y	Dantrolene	RYR2: ryanodine receptor 2 (cardiac)	0.31250	Phenytoin	0.66507	RYR1: ryanodine receptor 1 (skeletal)
70	N	N	N	N	Moricizine hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.43243	Dyclonine hydrochloride	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
71	N	N	N	N	Nortriptyline hydrochloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.86957	Amitriptyline hydrochloride	0.62986	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
72	N	N	N	N	Clozapine	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.37143	Ondansetron hydrochloride hydrate	0.50844	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
73	N	N	N	Y	Granisetron	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic	0.95833	Granisetron hydrochloride	0.31879	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
74	N	N	N	N	Amiloride hydrochloride	SCN4B: sodium channel, voltage-gated, type IV, beta subunit	0.26923	Riluzole	0.025789	ASIC2: acid-sensing (proton-gated) ion channel 2
75	N	N	N	N	Mexiletine hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.52381	Lidocaine hydrochloride	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
76	N	N	N	N	Chlorpromazine hibenzate	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.36364	Dequalinium chloride	0.63878	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
77	N	N	N	N	Etomidate	GABRR2	0.36667	Zaleplon	0.68315	GABRR1
78	Y	Y	N	N	Lamotrigine	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.40909	Riluzole	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
79	N	N	Y	N	Alprazolam	GABRR2	0.68000	Diazepam	0.68315	GABRR1
80	N	N	Y	N	Flurazepam	GABRR2	0.62069	Diazepam	0.68315	GABRR1
81	N	N	Y	N	Nicotine	CHRNA5: cholinergic receptor, nicotinic, alpha 5 (neuronal)	0.40909	Phencyclidine hydrochloride	0.44323	CHRNA2
82	N	N	Y	N	Methylphenidate	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.56000	Cocaine	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
83	N	N	N	N	Amiloride hydrochloride	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.26923	Riluzole	0.087772	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
84	N	N	N	N	Sumatriptan	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.28000	Dopamine hydrochloride	0.50844	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
85	N	N	N	Y	Ondansetron	HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic	0.88000	Ondansetron hydrochloride hydrate	0.40524	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
86	N	N	N	N	Pindolol	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.27273	Granisetron hydrochloride	0.50844	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
87	Y	N	Y	Y	Mazindol	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.55556	Amoxapine	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
88	N	N	N	N	Cyproheptadine hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.37500	Chlorpromazine hibenzate	0.62986	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
89	N	N	N	N	Chlorpromazine phenolphthalinate	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.30645	Dequalinium chloride	0.63878	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
90	N	N	N	N	Desipramine hydrochloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.72000	Amitriptyline hydrochloride	0.62986	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
91	N	N	N	N	Quinidine gluconate	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.25532	Levobupivacaine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
92	N	N	N	N	Amiloride hydrochloride	SCN1B: sodium channel, voltage-gated, type I, beta subunit	0.26923	Riluzole	0.024163	ASIC3: acid-sensing (proton-gated) ion channel 3
93	N	N	N	N	Verapamil hydrochloride	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.97059	Verapamil	0.66887	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
94	N	N	N	N	Tropisetron hydrochloride	GLRB: glycine receptor, beta	0.35484	Diazepam	0.39983	GLRA3
95	N	N	N	N	Amiloride hydrochloride	SCN3B: sodium channel, voltage-gated, type III, beta subunit	0.26923	Riluzole	0.024794	ASIC2: acid-sensing (proton-gated) ion channel 2
96	N	N	N	N	Bethanidine sulfate	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.25714	Phentermine	0.68182	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
97	N	N	N	N	Pentobarbital	GABRR2	0.16000	Propofol	0.68315	GABRR1
98	N	N	Y	Y	Zonisamide	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.36364	Lamotrigine	0.87680	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
99	N	N	N	N	Levetiracetam	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.29412	Ethosuximide	0.48256	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
100	N	N	N	N	Caffeine	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.93333	Caffeine hydrate	0.021666	P2RX4: purinergic receptor P2X, ligand-gated ion channel, 4
101	N	N	N	N	Flecainide acetate	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.27778	Quinidine gluconate	0.58884	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
102	N	N	N	N	Amitriptyline hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.41935	Fluoxetine	0.63878	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
103	N	N	N	N	Quinidine sulfate	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.20548	Verapamil	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
104	N	N	N	N	Diltiazem malate	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.33962	Verapamil	0.59825	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
105	N	N	N	N	Maprotiline	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.41379	Mazindol	0.68182	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
106	N	N	N	Y	Ondansetron	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic	0.88000	Ondansetron hydrochloride hydrate	0.31879	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
107	N	N	N	N	Verapamil hydrochloride	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.97059	Verapamil	0.66583	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
108	N	N	N	N	Verapamil hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.97059	Verapamil	0.53491	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
109	N	N	Y	N	Midazolam	GABRR2	0.59259	Diazepam	0.68315	GABRR1
110	N	N	N	N	Phenytoin	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.37500	Dizocilpine maleate	0.022827	SCN4B: sodium channel, voltage-gated, type IV, beta subunit
111	N	N	N	N	Verapamil	GRIA3: glutamate receptor, ionotropic, AMPA 3	0.20000	Riluzole	0.026689	KCNE1: potassium voltage-gated channel, Isk-related family, member 1
112	Y	N	N	N	Sertraline	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.57692	Maprotiline	0.49354	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
113	N	N	N	N	Diltiazem hydrochloride	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.39130	Verapamil hydrochloride	0.59825	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
114	N	N	N	N	Verapamil	GRIA4: glutamate receptor, ionotropic, AMPA 4	0.20000	Riluzole	0.026577	KCNE1: potassium voltage-gated channel, Isk-related family, member 1
115	N	N	Y	Y	Verapamil hydrochloride	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.97059	Verapamil	0.64082	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
116	N	N	N	N	Paramethadione	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.40000	Ethosuximide	0.47136	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
117	N	N	N	N	Flecainide acetate	KCNK5: potassium channel, subfamily K, member 5	0.38461	Dyclonine hydrochloride	0.030801	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
118	N	N	N	N	Trimethadione	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.33333	Ethosuximide	0.48256	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
119	N	N	N	N	Quinidine sulfate	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	1	Quinine sulfate	0.56382	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
120	N	N	N	N	Diazoxide	KCNK12: potassium channel, subfamily K, member 12	0.050000	Halothane	0.61540	KCNK13: potassium channel, subfamily K, member 13
121	N	N	N	N	Gallopamil hydrochloride	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	0.89189	Verapamil hydrochloride	0.021436	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
122	N	N	N	N	Benoxinate hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.80000	Proparacaine hydrochloride	0.60410	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
123	N	N	N	N	Isoflurane	GABRR2	0.095238	Propofol	0.68315	GABRR1
124	N	N	N	N	Dofetilide	KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 1	0.40909	Verapamil	0.74648	KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5
125	N	N	N	N	Promethazine hydrochloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.65385	Amitriptyline hydrochloride	0.62986	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
126	N	N	N	N	Levetiracetam	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.29412	Ethosuximide	0.44753	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
127	N	N	N	N	Gabapentin	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.26316	Levetiracetam	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
128	N	N	N	N	Verapamil	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.34091	Propafenone hydrochloride	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
129	N	N	N	N	Mibefradil dihydrochloride	CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit	0.44898	Verapamil	0.58498	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
130	N	N	N	N	Guanadrel sulfate	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.083333	Methylphenidate	0.68182	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
131	N	N	N	N	Dequalinium chloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.42500	Desipramine hydrochloride	0.55275	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
132	N	N	N	N	Dequalinium chloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.41463	Amitriptyline hydrochloride	0.63878	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
133	N	N	N	N	Carbachol	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.29167	Metoclopramide	0.42466	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)
134	N	N	N	N	Promethazine teoclate	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.43590	Amitriptyline hydrochloride	0.62986	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
135	N	N	N	N	Guanethidine sulfate	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.086957	Methylphenidate	0.68182	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
136	N	N	N	N	Ibutilide fumarate	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit	0.30667	Diltiazem malate	0.57786	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
137	N	N	N	N	Zaleplon	GLRB: glycine receptor, beta	0.30303	Diazepam	0.29609	GABRB1: gamma-aminobutyric acid (GABA) A receptor, beta 1
138	N	N	N	N	Verapamil	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.34091	Propafenone hydrochloride	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
139	N	N	N	N	Mibefradil dihydrochloride	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit	0.46939	Verapamil hydrochloride	0.29326	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit
140	N	N	N	N	Maprotiline	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.57692	Sertraline	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
141	N	N	N	Y	Mirtazapine	HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic	0.53571	Clozapine	0.40524	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
142	N	N	N	Y	Prilocaine	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.94118	Prilocaine hydrochloride	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
143	Y	N	Y	Y	Diazoxide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.32000	Glyclopyramide	0.66902	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8
144	N	N	N	N	Verapamil	ASIC2: acid-sensing (proton-gated) ion channel 2	0.085106	Amiloride hydrochloride	0.48895	ASIC3: acid-sensing (proton-gated) ion channel 3
145	N	N	N	N	Verapamil	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.34091	Propafenone hydrochloride	0.72659	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
146	N	N	N	Y	Disopyramide	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.45714	Propafenone hydrochloride	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
147	N	N	Y	Y	Zonisamide	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.36364	Lamotrigine	0.76982	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
148	N	N	N	N	Methylphenidate	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.56000	Cocaine	0.44420	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
149	N	N	N	N	Flecainide acetate	KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 6	0.20370	Verapamil	0.60832	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
150	N	N	N	N	Lamotrigine	KCNK5: potassium channel, subfamily K, member 5	0.30435	Diazoxide	0.013225	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
151	N	N	Y	N	Verapamil	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.29167	Ibutilide fumarate	0.66902	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8
152	N	N	N	Y	Benzocaine	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.57895	Procaine hydrochloride	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
153	N	N	N	N	Verapamil	ASIC1: acid-sensing (proton-gated) ion channel 1	0.085106	Amiloride hydrochloride	0.47336	ASIC3: acid-sensing (proton-gated) ion channel 3
154	N	N	N	N	Cocaine	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	0.11111	Proline	0.42834	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1
155	N	N	Y	N	Glimepiride	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.58537	Glipizide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
156	N	N	N	N	Verapamil	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.34091	Propafenone hydrochloride	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
157	N	N	N	N	Tubocurarine chloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.28169	Chlorpromazine hibenzate	0.62986	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
158	N	N	N	N	Ethotoin	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.72222	Primidone	0.0092349	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
159	N	N	N	N	Gallopamil hydrochloride	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.86486	Verapamil	0.28502	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
160	N	N	N	N	Pentobarbital	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.16129	Metoclopramide	0.42466	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)
161	N	N	N	N	Carbachol	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.29167	Metoclopramide	0.37214	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
162	N	N	N	N	Isradipine	CACNA2D3: calcium channel, voltage-dependent, alpha 2/delta subunit 3	0.66667	Nisoldipine	0.61055	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4
163	N	N	N	N	Gallopamil hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.89189	Verapamil hydrochloride	0.012103	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
164	N	N	N	N	Diazoxide	GRID2: glutamate receptor, ionotropic, delta 2	0.38095	Riluzole	0.19653	GRIA2: glutamate receptor, ionotropic, AMPA 2
165	N	N	Y	N	Phentermine	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.32000	Cocaine	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
166	Y	N	N	N	Nicotine	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.14286	Metoclopramide	0.42466	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)
167	Y	N	Y	N	Paroxetine	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.48387	Amoxapine	0.49354	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
168	N	N	N	N	Etomidate	GLRA1: glycine receptor, alpha 1	0.40000	Felbamate	0.32784	GABRA2: gamma-aminobutyric acid (GABA) A receptor, alpha 2
169	N	N	N	N	Riluzole	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.40909	Lamotrigine	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
170	N	N	N	Y	Zonisamide	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.36364	Lamotrigine	0.75242	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
171	N	N	N	N	Verapamil hydrochloride	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1	0.97059	Verapamil	0.63973	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
172	N	N	N	Y	Tolbutamide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.56000	Tolazamide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
173	N	N	N	N	Isradipine	CACNB1: calcium channel, voltage-dependent, beta 1 subunit	0.66667	Nisoldipine	0.56271	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
174	N	N	N	N	Ibutilide fumarate	CACNB2: calcium channel, voltage-dependent, beta 2 subunit	0.29167	Verapamil	0.56271	CACNB1: calcium channel, voltage-dependent, beta 1 subunit
175	N	N	N	N	Gallopamil hydrochloride	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.89189	Verapamil hydrochloride	0.022438	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
176	N	N	N	N	Doxorubicin hydrochloride	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.23729	Glyburide	0.0043818	RYR2: ryanodine receptor 2 (cardiac)
177	N	N	N	N	Pentobarbital	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.16129	Metoclopramide	0.37214	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
178	N	N	N	N	Diltiazem hydrochloride	KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 6	0.36956	Verapamil	0.60832	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
179	N	N	N	N	Phenacemide	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.42105	Tocainide	0.60301	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
180	N	N	N	N	Nicotine	HTR3B: 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic	0.36000	Tropisetron hydrochloride	0.40524	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
181	N	N	N	Y	Carbamazepine	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.40000	Moricizine hydrochloride	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
182	N	N	N	N	Diltiazem hydrochloride	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.39130	Verapamil hydrochloride	0.58819	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
183	N	N	N	N	Diltiazem malate	KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 6	0.33962	Verapamil	0.60832	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
184	N	N	N	N	Flecainide acetate	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.28302	Ketoconazole	0.58819	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
185	Y	N	N	N	Nicotine	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.14286	Metoclopramide	0.37214	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
186	N	N	N	N	Verapamil hydrochloride	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.97059	Verapamil	0.54817	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
187	N	N	N	N	Quinine sulfate	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	1	Quinidine sulfate	0.56382	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
188	N	N	N	N	Diltiazem malate	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.33962	Verapamil	0.58884	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
189	N	N	N	N	Kainic acid hydrate	GRID2: glutamate receptor, ionotropic, delta 2	0	Riluzole	0.20292	GRIK2: glutamate receptor, ionotropic, kainate 2
190	N	N	N	N	Furosemide	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.51613	Benzthiazide	0.011447	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
191	N	N	N	N	Mibefradil dihydrochloride	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit	0.46939	Verapamil hydrochloride	0.28734	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit
192	N	N	N	N	Cocaine	SLC6A14: solute carrier family 6 (amino acid transporter), member 14	0.11111	Proline	0.38828	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1
193	N	N	N	N	Trifluoperazine hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.51429	Fluoxetine hydrochloride	0.63878	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
194	N	N	N	N	Verapamil	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.20000	Riluzole	0.027448	KCNE1: potassium voltage-gated channel, Isk-related family, member 1
195	N	N	N	N	Diltiazem hydrochloride	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.40425	Nicardipine hydrochloride	0.58884	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
196	N	N	Y	N	Isradipine	CACNA2D2: calcium channel, voltage-dependent, alpha 2/delta subunit 2	0.66667	Nisoldipine	0.52208	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
197	N	N	N	N	Cyproheptadine hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.39317	Tubocurarine chloride	0.63878	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
198	N	N	N	Y	Topiramate	GRIK3: glutamate receptor, ionotropic, kainate 3	0.15152	Kainic acid hydrate	0.72331	GRIK1: glutamate receptor, ionotropic, kainate 1
199	N	N	N	N	Profenamine hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.76000	Promethazine hydrochloride	0.013549	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
200	N	N	N	N	Gabapentin	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.096774	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
201	N	N	N	N	Gabapentin	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.25926	Dyclonine hydrochloride	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
202	N	N	N	N	Diltiazem malate	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.38182	Mibefradil dihydrochloride	0.28502	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
203	N	N	N	N	Quinine sulfate	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	1	Quinidine sulfate	0.53491	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
204	N	N	N	Y	Granisetron	HTR3C	0.95833	Granisetron hydrochloride	0.31377	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
205	N	N	N	N	Isradipine	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.66667	Nisoldipine	0.29326	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
206	N	N	N	N	Doxorubicin hydrochloride	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.24624	Ketoconazole	0.0071212	RYR2: ryanodine receptor 2 (cardiac)
207	N	N	N	N	Phenytoin	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.17143	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
208	N	N	N	N	Streptomycin sulfate	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.066667	Glyburide	0.0043818	RYR2: ryanodine receptor 2 (cardiac)
209	N	N	N	N	Quinidine gluconate	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.31579	Diltiazem malate	0.58845	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
210	N	N	N	N	Verapamil	MCOLN1: mucolipin 1	0.085106	Amiloride hydrochloride	0.032255	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
211	N	N	Y	N	Magnesium sulfate	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit	0.062500	Amlodipine besylate	0.57786	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
212	N	N	N	N	Riluzole	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.40909	Lamotrigine	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
213	N	N	N	Y	Acetohexamide	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.61765	Glyburide	0.013742	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
214	Y	N	Y	Y	Glyburide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.77778	Glipizide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
215	N	N	N	N	Nimodipine	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.75000	Nitrendipine	0.12954	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
216	N	N	N	N	Zaleplon	GLRA2: glycine receptor, alpha 2	0.30303	Diazepam	0.32569	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
217	N	N	N	N	Haloperidol	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.42492	Thioridazine hydrochloride	0.015023	GRIN2C: glutamate receptor, ionotropic, N-methyl D-aspartate 2C
218	N	N	N	N	Diltiazem malate	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.33962	Verapamil	0.58819	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
219	N	Y	N	N	Halothane	RYR2: ryanodine receptor 2 (cardiac)	0.078947	Pimozide	0.021708	ITPR3: inositol 1,4,5-trisphosphate receptor, type 3
220	N	N	N	Y	Metoclopramide	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.28000	Dopamine hydrochloride	0.50844	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
221	N	N	N	Y	Dibucaine	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.48276	Procainamide hydrochloride	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
222	N	N	N	N	Verapamil	TRPC6: transient receptor potential cation channel, subfamily C, member 6	0.085106	Amiloride hydrochloride	0.027859	KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
223	N	N	N	N	Carbachol	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.29167	Metoclopramide	0.26265	CHRNA10: cholinergic receptor, nicotinic, alpha 10 (neuronal)
224	N	Y	N	N	Halothane	RYR3	0.078947	Pimozide	0.021825	ITPR3: inositol 1,4,5-trisphosphate receptor, type 3
225	N	N	N	N	Riluzole	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.12121	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
226	N	N	N	Y	Mirtazapine	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic	0.53571	Clozapine	0.31879	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
227	N	N	N	Y	Cocaine	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.36000	Benzocaine	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
228	N	N	N	N	Riluzole	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.45833	Hydroflumethiazide	0.016547	SCN1B: sodium channel, voltage-gated, type I, beta subunit
229	N	N	N	N	Ethosuximide	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.47059	Butabarbital	0.011438	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
230	N	N	N	N	Gallopamil hydrochloride	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.89189	Verapamil hydrochloride	0.022185	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
231	N	N	N	N	Mibefradil dihydrochloride	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.44898	Verapamil	0.27185	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
232	N	N	N	N	Ibutilide fumarate	KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5	0.41270	Dofetilide	0.27171	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6
233	N	N	N	N	Ibutilide fumarate	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit	0.30667	Diltiazem malate	0.56053	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
234	N	N	N	N	Dofetilide	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.41270	Ibutilide fumarate	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
235	N	N	N	Y	Topiramate	GRIK2: glutamate receptor, ionotropic, kainate 2	0.15152	Kainic acid hydrate	0.76835	GRIK1: glutamate receptor, ionotropic, kainate 1
236	N	N	N	N	Dofetilide	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.41270	Ibutilide fumarate	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
237	N	N	N	N	Quinine sulfate	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	1	Quinidine sulfate	0.54817	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
238	N	N	N	N	Nimodipine	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.75000	Nitrendipine	0.11063	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
239	N	N	N	N	Propafenone hydrochloride	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.45000	Amiodarone hydrochloride	0.51877	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
240	N	N	N	N	Granisetron hydrochloride	GLRA3	0.53333	Tropisetron hydrochloride	0.095753	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
241	N	N	N	N	Etomidate	GLRB: glycine receptor, beta	0.40000	Felbamate	0.29609	GABRB1
242	N	N	N	N	Penfluridol	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.64729	Pimozide	0.12631	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
243	N	N	N	Y	Granisetron	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.95833	Granisetron hydrochloride	0.16111	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
244	N	N	N	N	Phentermine	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.32000	Cocaine	0.44420	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
245	N	N	N	N	Diltiazem hydrochloride	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.44681	Mibefradil dihydrochloride	0.28502	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
246	N	N	N	N	Trimipramine	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.72000	Promethazine hydrochloride	0.017087	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
247	N	N	Y	Y	Phenytoin	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.36364	Propafenone hydrochloride	0.83065	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
248	N	Y	N	N	Felodipine	CACNG1: calcium channel, voltage-dependent, gamma subunit 1	0.75862	Nitrendipine	0.018083	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
249	N	N	N	N	Magnesium sulfate	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.062500	Amlodipine besylate	0.64082	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
250	N	N	N	N	Mibefradil dihydrochloride	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit	0.44898	Verapamil	0.27364	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit
251	N	N	N	N	Verapamil hydrochloride	KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 6	0.97059	Verapamil	0.57211	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
252	N	N	N	N	Gabapentin	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.25926	Dyclonine hydrochloride	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
253	N	N	N	N	Etomidate	GLRA2: glycine receptor, alpha 2	0.40000	Felbamate	0.32569	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
254	N	N	N	N	Levobupivacaine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.95652	Bupivacaine hydrochloride	0.026637	KCNK5: potassium channel, subfamily K, member 5
255	N	N	N	N	Kainic acid hydrate	GRIA3: glutamate receptor, ionotropic, AMPA 3	0.034483	Diazoxide	0.35489	GRIK2: glutamate receptor, ionotropic, kainate 2
256	N	N	N	N	Verapamil	CLCN2: chloride channel, voltage-sensitive 2	0.11111	Lubiprostone	0.022598	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
257	N	N	N	N	Nimodipine	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.75000	Nitrendipine	0.10257	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
258	N	N	N	N	Quinidine sulfate	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	1	Quinine sulfate	0.20403	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
259	N	N	N	Y	Topiramate	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.20000	Mexiletine hydrochloride	0.87680	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
260	N	N	N	N	Levetiracetam	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.30769	Dyclonine hydrochloride	0.87680	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
261	N	N	N	N	Riluzole	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.40909	Lamotrigine	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
262	N	N	N	N	Verapamil	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.29412	Glyburide	0.15287	ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9
263	N	N	N	N	Kainic acid hydrate	GRIA4: glutamate receptor, ionotropic, AMPA 4	0.034483	Diazoxide	0.34506	GRIK2: glutamate receptor, ionotropic, kainate 2
264	N	N	N	N	Trifluoperazine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.64706	Thioridazine hydrochloride	0.030674	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
265	N	N	N	N	Gallopamil hydrochloride	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2	0.89189	Verapamil hydrochloride	0.022846	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
266	N	N	N	N	Magnesium sulfate	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit	0.062500	Amlodipine besylate	0.56053	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
267	N	N	N	N	Nicotine	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic	0.36000	Tropisetron hydrochloride	0.31879	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
268	N	N	N	N	Aminoglutethimide	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.57143	Primidone	0.090264	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
269	N	Y	N	N	Felodipine	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4	0.75862	Nitrendipine	0.0092209	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
270	N	N	N	N	Enflurane	GLRA2: glycine receptor, alpha 2	0.46667	Sevoflurane	0.76918	GLRA1: glycine receptor, alpha 1
271	N	Y	Y	N	Felodipine	CACNB2: calcium channel, voltage-dependent, beta 2 subunit	0.75862	Nitrendipine	0.017211	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
272	N	N	N	N	Gabapentin	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.25926	Dyclonine hydrochloride	0.72659	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
273	Y	N	N	Y	Phenytoin	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.36364	Propafenone hydrochloride	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
274	N	N	N	Y	Dibucaine	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.48276	Procainamide hydrochloride	0.60341	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
275	N	N	N	N	Trifluoperazine maleate	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.34694	Fluoxetine	0.63878	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
276	N	N	N	Y	Cocaine	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.36000	Benzocaine	0.60341	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
277	N	N	N	N	Nateglinide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.45161	Gliclazide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
278	N	N	N	N	Quinidine gluconate	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	0.60000	Quinine hydrochloride hydrate	0.56382	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
279	N	Y	Y	Y	Glipizide	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.77778	Glyburide	0.013742	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
280	N	N	N	N	Zaleplon	GLRA1: glycine receptor, alpha 1	0.30303	Diazepam	0.32784	GABRA2
281	N	N	N	N	Streptomycin sulfate	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.075630	Verapamil	0.0071212	RYR2: ryanodine receptor 2 (cardiac)
282	N	N	Y	N	Verapamil hydrochloride	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.97059	Verapamil	0.023050	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
283	N	N	N	N	Riluzole	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.40909	Lamotrigine	0.72659	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
284	N	N	N	N	Pentobarbital	GLRB: glycine receptor, beta	0.16000	Propofol	0.29609	GABRB1
285	N	N	N	N	Methoxyflurane	GLRA2: glycine receptor, alpha 2	0.33333	Sevoflurane	0.76918	GLRA1: glycine receptor, alpha 1
286	N	N	N	N	Dofetilide	KCNK10: potassium channel, subfamily K, member 10	0.40909	Verapamil	0.51272	KCNK2: potassium channel, subfamily K, member 2
287	N	N	N	N	Ibutilide fumarate	CACNA1D: calcium channel, voltage-dependent, L type, alpha 1D subunit	0.29167	Verapamil	0.64082	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
288	N	N	N	N	Propofol	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.22727	Diazoxide	0.018959	GLRA1: glycine receptor, alpha 1
289	N	N	N	N	Butabarbital	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.82353	Pentobarbital	0.090264	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
290	N	N	N	N	Nicardipine hydrochloride	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.67568	Nitrendipine	0.51802	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
291	N	N	N	N	Thioridazine hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.56757	Fluphenazine hydrochloride	0.024221	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
292	N	N	N	N	Mazindol	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.20000	Cocaine	0.44420	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
293	N	N	N	N	Kainic acid hydrate	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.11111	Cyclothiazide	0.36035	GRIK2: glutamate receptor, ionotropic, kainate 2
294	N	N	N	N	Tubocurarine chloride	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.21311	Letrozole	0.44784	CHRNA2
295	N	N	N	N	Quinidine sulfate	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.20779	Diltiazem malate	0.58845	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
296	N	N	N	N	Aminoglutethimide	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.32000	Pentobarbital	0.31850	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
297	N	Y	N	N	Felbamate	GABRR2	0.20000	Propofol	0.29902	GLRA2: glycine receptor, alpha 2
298	N	N	N	N	Metocurine iodide	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.67619	Tubocurarine chloride	0.018097	CHRNA2
299	N	N	N	N	Phenacemide	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.40000	Tocainide hydrochloride	0.87680	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
300	N	N	N	N	Ibutilide fumarate	KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 1	0.29167	Verapamil	0.28151	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6
301	N	Y	N	N	Halothane	RYR1: ryanodine receptor 1 (skeletal)	0.078947	Pimozide	0.021654	ITPR1: inositol 1,4,5-trisphosphate receptor, type 1
302	N	N	N	N	Caffeine hydrate	P2RX4: purinergic receptor P2X, ligand-gated ion channel, 4	0.93333	Caffeine	0.021666	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
303	N	N	N	N	Nicardipine hydrochloride	CACNG1: calcium channel, voltage-dependent, gamma subunit 1	0.67568	Nitrendipine	0.019066	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
304	N	N	Y	N	Verapamil hydrochloride	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.97059	Verapamil	0.28502	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
305	N	N	N	Y	Phenytoin	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.36364	Propafenone hydrochloride	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
306	N	N	N	N	Trimipramine	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.25714	Cocaine	0.43128	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
307	N	N	N	N	Ropivacaine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.87500	Bupivacaine hydrochloride	0.026637	KCNK5: potassium channel, subfamily K, member 5
308	N	N	N	N	Exemestane	CHRNA2	0.27273	Dextromethorphan	0.44784	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
309	N	N	N	N	Dextromethorphan	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.37037	Methylphenidate	0.49354	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
310	N	N	N	N	Ketamine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.38710	Thioridazine hydrochloride	0.024001	GABRA6: gamma-aminobutyric acid (GABA) A receptor, alpha 6
311	N	N	N	N	Caffeine hydrate	P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1	0.93333	Caffeine	0.019059	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
312	N	N	Y	N	Nimodipine	CACNB1: calcium channel, voltage-dependent, beta 1 subunit	0.75000	Nitrendipine	0.56271	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
313	N	N	N	N	Tubocurarine chloride	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2	0.23975	Midazolam	0.43368	GABRA6
314	N	N	N	Y	Ondansetron	HTR3C	0.88000	Ondansetron hydrochloride hydrate	0.31377	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
315	N	N	N	N	Amlodipine besylate	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.48837	Nitrendipine	0.51802	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
316	N	N	N	N	Caffeine hydrate	P2RX3: purinergic receptor P2X, ligand-gated ion channel, 3	0.93333	Caffeine	0.016400	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
317	N	N	N	N	Caffeine hydrate	P2RX5: purinergic receptor P2X, ligand-gated ion channel, 5	0.93333	Caffeine	0.019642	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
318	N	N	N	N	Caffeine hydrate	P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6	0.93333	Caffeine	0.015356	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
319	N	N	N	N	Quinine hydrochloride hydrate	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.60000	Quinidine gluconate	0.53491	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
320	N	N	N	Y	Oxcarbazepine	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.76191	Carbamazepine	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
321	N	N	N	N	Quinidine gluconate	KCNK4: potassium channel, subfamily K, member 4	0.18644	Verapamil	0.38351	KCNK2: potassium channel, subfamily K, member 2
322	N	N	N	N	Amoxapine	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.22222	Cocaine	0.43128	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
323	N	N	N	N	Oxcarbazepine	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.76191	Carbamazepine	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
324	N	N	N	N	Ibutilide fumarate	CACNA2D2: calcium channel, voltage-dependent, alpha 2/delta subunit 2	0.29167	Verapamil	0.52208	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
325	N	N	N	N	Halothane	GLRA2: glycine receptor, alpha 2	0.46154	Sevoflurane	0.76918	GLRA1: glycine receptor, alpha 1
326	N	N	Y	N	Quinidine gluconate	KCNK1: potassium channel, subfamily K, member 1	0.21250	Ibutilide fumarate	0.38862	KCNK6: potassium channel, subfamily K, member 6
327	N	N	N	N	Diazoxide	GRIK5: glutamate receptor, ionotropic, kainate 5	0.38095	Riluzole	0.29524	GRIA3: glutamate receptor, ionotropic, AMPA 3
328	N	N	N	N	Desflurane	GLRA2: glycine receptor, alpha 2	0.57143	Sevoflurane	0.76918	GLRA1: glycine receptor, alpha 1
329	N	N	N	N	Propofol	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.26471	Diltiazem hydrochloride	0.019626	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
330	N	N	Y	Y	Glimepiride	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.55814	Glyburide	0.013742	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
331	N	N	N	N	Proline	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.11111	Cocaine	0.42834	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
332	N	N	N	Y	Mecamylamine hydrochloride	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.20690	Exemestane	0.44784	CHRNA2
333	N	N	Y	N	Nicardipine hydrochloride	CACNB2: calcium channel, voltage-dependent, beta 2 subunit	0.67568	Nitrendipine	0.021060	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
334	N	N	N	Y	Tocainide	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.93333	Tocainide hydrochloride	0.60301	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
335	N	N	N	N	Nicardipine hydrochloride	CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit	0.67568	Nitrendipine	0.58498	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
336	N	N	N	N	Magnesium sulfate	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4	0.027027	Nifedipine	0.19447	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
337	N	N	N	N	Caffeine hydrate	P2RX7: purinergic receptor P2X, ligand-gated ion channel, 7	0.93333	Caffeine	0.013336	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
338	N	N	N	N	Isradipine	CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit	0.66667	Nisoldipine	0.29050	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
339	N	N	N	N	Nimodipine	CACNA2D3: calcium channel, voltage-dependent, alpha 2/delta subunit 3	0.75000	Nitrendipine	0.61055	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4
340	N	N	N	N	Caffeine hydrate	P2RX2: purinergic receptor P2X, ligand-gated ion channel, 2	0.93333	Caffeine	0.017000	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
341	N	N	N	N	Diazoxide	GRIK4: glutamate receptor, ionotropic, kainate 4	0.38095	Riluzole	0.29011	GRIA1: glutamate receptor, ionotropic, AMPA 1
342	N	N	N	N	Isradipine	CACNB4: calcium channel, voltage-dependent, beta 4 subunit	0.66667	Nisoldipine	0.54913	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
343	N	N	N	N	Paramethadione	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.30435	Methohexital	0.011438	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
344	N	N	N	N	Desflurane	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.23529	Flecainide acetate	0.79208	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
345	N	N	N	N	Maprotiline	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.68000	Desipramine hydrochloride	0.017087	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
346	N	N	Y	N	Amlodipine besylate	CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit	0.48837	Nitrendipine	0.58498	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
347	N	N	N	Y	Phenytoin	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.36364	Propafenone hydrochloride	0.72659	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
348	N	N	N	N	Diazoxide	GRIK3: glutamate receptor, ionotropic, kainate 3	0.38095	Riluzole	0.34712	GRIA2: glutamate receptor, ionotropic, AMPA 2
349	N	N	N	N	Verapamil hydrochloride	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.97059	Verapamil	0.20857	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
350	Y	N	Y	N	Glyburide	ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9	0.29412	Verapamil	0.68192	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
351	N	N	N	N	Nicardipine hydrochloride	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4	0.67568	Nitrendipine	0.010062	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
352	N	N	N	N	Quinidine sulfate	KCNK4: potassium channel, subfamily K, member 4	0.20548	Verapamil	0.38351	KCNK2: potassium channel, subfamily K, member 2
353	N	N	N	N	Quinidine sulfate	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.20548	Verapamil	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
354	N	Y	N	N	Verapamil	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.29268	Metoclopramide	0.029958	KCNE3: potassium voltage-gated channel, Isk-related family, member 3
355	N	N	N	N	Diazoxide	GRIK2: glutamate receptor, ionotropic, kainate 2	0.034483	Kainic acid hydrate	0.36035	GRIA2: glutamate receptor, ionotropic, AMPA 2
356	N	N	N	N	Levetiracetam	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.30769	Dyclonine hydrochloride	0.76982	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
357	N	N	N	N	Bethanidine sulfate	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.30952	Trimipramine	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
358	N	N	N	N	Quinine sulfate	KCNK2: potassium channel, subfamily K, member 2	1	Quinidine sulfate	0.034129	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
359	N	N	N	N	Verapamil hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.97059	Verapamil	0.029136	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
360	N	N	N	N	Verapamil	GRID2: glutamate receptor, ionotropic, delta 2	0.20000	Riluzole	0.020345	KCNE1L: KCNE1-like
361	N	N	N	N	Alprazolam	GLRA1: glycine receptor, alpha 1	0.68000	Diazepam	0.32784	GABRA2
362	N	N	N	N	Metocurine iodide	CHRNA4: cholinergic receptor, nicotinic, alpha 4 (neuronal)	0.67619	Tubocurarine chloride	0.52847	CHRNA2
363	N	N	N	N	Dofetilide	KCNK6: potassium channel, subfamily K, member 6	0.41270	Ibutilide fumarate	0.19314	KCNK2: potassium channel, subfamily K, member 2
364	N	N	N	Y	Hexamethonium bromide	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.35000	Carbachol	0.44784	CHRNA2
365	N	N	N	N	Moricizine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.52632	Loratadine	0.016875	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
366	N	N	N	N	Metocurine iodide	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)	0.67619	Tubocurarine chloride	0.52424	CHRNA2
367	N	N	N	N	Flurazepam	GLRB: glycine receptor, beta	0.62069	Diazepam	0.29609	GABRB1
368	N	N	N	N	Levetiracetam	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.30769	Dyclonine hydrochloride	0.75242	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
369	N	N	N	N	Verapamil	P2RX2: purinergic receptor P2X, ligand-gated ion channel, 2	0.17500	Caffeine	0.042682	KCNK4: potassium channel, subfamily K, member 4
370	N	N	N	N	Diazoxide	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.27027	Glyburide	0.14579	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
371	N	N	N	N	Flecainide acetate	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.27027	Riluzole	0.015652	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
372	N	N	N	Y	Topiramate	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.20000	Mexiletine hydrochloride	0.76982	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
373	N	N	N	N	Alprazolam	GLRB: glycine receptor, beta	0.68000	Diazepam	0.29609	GABRB1
374	N	Y	N	N	Verapamil	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.29268	Metoclopramide	0.035142	KCNK4: potassium channel, subfamily K, member 4
375	N	N	N	N	Indapamide	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.42857	Benzthiazide	0.022575	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
376	N	N	N	N	Amlexanox	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.38235	Caffeine and sodium benzoate	0.14579	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
377	N	N	N	N	Quinine sulfate	KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5	1	Quinidine sulfate	0.015687	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
378	N	N	N	N	Bupivacaine hydrochloride	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.34146	Flecainide acetate	0.51877	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
379	N	N	N	N	Penfluridol	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	0.64729	Pimozide	0.11362	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
380	N	N	N	Y	Disopyramide	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.45714	Propafenone hydrochloride	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
381	N	N	N	N	Tolbutamide	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.41667	Glyburide	0.14579	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
382	N	N	N	Y	Topiramate	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.20000	Mexiletine hydrochloride	0.75242	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
383	N	N	N	N	Isoflurane	GLRA3	0.032258	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
384	N	N	N	Y	Oxcarbazepine	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.76191	Carbamazepine	0.60341	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
385	N	N	N	N	Pentobarbital	GLRA1: glycine receptor, alpha 1	0.16000	Propofol	0.32784	GABRA2
386	N	N	N	N	Levetiracetam	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.26087	Ketamine hydrochloride	0.0099594	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
387	N	N	N	N	Nortriptyline hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.48276	Fluoxetine	0.55275	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
388	N	N	N	N	Isradipine	CACNB3: calcium channel, voltage-dependent, beta 3 subunit	0.66667	Nisoldipine	0.48563	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
389	N	N	N	Y	Ondansetron	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.88000	Ondansetron hydrochloride hydrate	0.16111	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
390	N	N	N	N	Amitriptyline hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.50000	Thioridazine hydrochloride	0.030674	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
391	N	N	N	N	Diazoxide	CLCN2: chloride channel, voltage-sensitive 2	0.051282	Lubiprostone	0.022598	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
392	N	N	N	N	Verapamil	SLC6A14: solute carrier family 6 (amino acid transporter), member 14	0	Proline	0.033290	KCNK17: potassium channel, subfamily K, member 17
393	N	N	N	N	Quinidine gluconate	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.31579	Diltiazem malate	0.59825	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
394	N	N	N	N	Ibutilide fumarate	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4	0.29167	Verapamil	0.19447	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
395	N	N	N	N	Guanadrel sulfate	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.17021	Dextromethorphan	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
396	N	N	N	N	Anastrozole	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.23529	Metoclopramide	0.31850	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
397	N	N	N	N	Ethosuximide	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.15790	Gabapentin	0.12631	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
398	N	N	N	N	Ibutilide fumarate	CACNB4: calcium channel, voltage-dependent, beta 4 subunit	0.29167	Verapamil	0.56963	CACNB1: calcium channel, voltage-dependent, beta 1 subunit
399	N	N	N	N	Amlexanox	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.37500	Repaglinide	0.013742	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
400	N	N	N	N	Desipramine hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.48276	Fluoxetine	0.55275	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
401	N	N	N	N	Verapamil	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	0	Proline	0.031499	KCNK16: potassium channel, subfamily K, member 16
402	N	N	Y	N	Quinidine sulfate	KCNK1: potassium channel, subfamily K, member 1	0.20548	Verapamil	0.38862	KCNK6: potassium channel, subfamily K, member 6
403	N	N	N	N	Gallopamil hydrochloride	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.86486	Verapamil	0.0095753	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
404	N	N	N	N	Isradipine	PKD1: polycystic kidney disease 1 (autosomal dominant)	0.66667	Nisoldipine	0.0092008	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
405	N	N	N	N	Enflurane	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.20000	Flecainide acetate	0.79208	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
406	N	N	N	N	Phenacemide	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.40000	Tocainide hydrochloride	0.83065	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
407	N	N	N	N	Quinine sulfate	KCNK10: potassium channel, subfamily K, member 10	1	Quinidine sulfate	0.029311	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
408	N	N	N	N	Riluzole	ASIC1: acid-sensing (proton-gated) ion channel 1	0.26923	Amiloride hydrochloride	0.47336	ASIC3: acid-sensing (proton-gated) ion channel 3
409	N	N	N	N	Quinidine gluconate	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.19231	Disopyramide	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
410	N	N	N	N	Encainide hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.47059	Bupivacaine hydrochloride	0.016875	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
411	N	N	N	N	Halothane	GLRA3	0.035714	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
412	N	N	N	N	Riluzole	ASIC2: acid-sensing (proton-gated) ion channel 2	0.26923	Amiloride hydrochloride	0.48895	ASIC3: acid-sensing (proton-gated) ion channel 3
413	N	N	N	N	Trimipramine	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.51852	Oxcarbazepine	0.013973	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
414	N	Y	N	N	Riluzole	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.23077	Ketamine hydrochloride	0.44349	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
415	N	N	N	N	Quinine sulfate	KCNK6: potassium channel, subfamily K, member 6	1	Quinidine sulfate	0.041460	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
416	N	N	N	N	Prilocaine	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.94118	Prilocaine hydrochloride	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
417	N	N	N	N	Verapamil	GLRA3	0.14583	Tropisetron hydrochloride	0.029733	KCNE1L: KCNE1-like
418	N	N	N	N	Flurazepam	GLRA1: glycine receptor, alpha 1	0.62069	Diazepam	0.32784	GABRA2
419	N	N	N	N	Verapamil hydrochloride	KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 4	0.97059	Verapamil	0.63607	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
420	N	Y	N	N	Felodipine	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.75862	Nitrendipine	0.51802	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
421	N	N	N	N	Penfluridol	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.48936	Astemizole	0.013728	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
422	N	N	N	Y	Prilocaine	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.94118	Prilocaine hydrochloride	0.60301	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
423	N	N	N	N	Phencyclidine hydrochloride	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.40909	Nicotine	0.44784	CHRNA2
424	N	N	N	N	Metocurine iodide	CHRNA6: cholinergic receptor, nicotinic, alpha 6 (neuronal)	0.67619	Tubocurarine chloride	0.49191	CHRNA2
425	N	N	N	N	Quinine sulfate	KCNK16: potassium channel, subfamily K, member 16	1	Quinidine sulfate	0.033222	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
426	N	N	N	N	Mitiglinide calcium hydrate	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.30909	Nateglinide	0.39373	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
427	N	N	N	N	Tubocurarine chloride	GABRG3: gamma-aminobutyric acid (GABA) A receptor, gamma 3	0.23975	Midazolam	0.40101	GABRA6
428	N	N	N	N	Midazolam	GLRA1: glycine receptor, alpha 1	0.59259	Diazepam	0.32784	GABRA2
429	N	N	N	N	Ketamine hydrochloride	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2	0.37500	Flurazepam	0.43368	GABRA6
430	Y	N	Y	N	Pimozide	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.65854	Astemizole	0.017111	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
431	N	N	N	N	Phenacemide	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.40000	Tocainide hydrochloride	0.76982	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
432	N	N	N	N	Lubiprostone	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.25926	Penicillin G procaine	0.013899	CLCN2: chloride channel, voltage-sensitive 2
433	N	N	N	N	Verapamil	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.12245	Cocaine	0.033720	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
434	N	N	N	N	Quinine sulfate	KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 1	1	Quinidine sulfate	0.016688	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
435	N	N	N	N	Hexamethonium bromide	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.35000	Carbachol	0.31221	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
436	N	N	N	N	Pentobarbital	GLRA2: glycine receptor, alpha 2	0.16000	Propofol	0.32569	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
437	N	N	N	N	Phenacemide	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.40000	Tocainide hydrochloride	0.75242	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
438	N	N	Y	N	Nicotine bitartrate	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.35294	Nicotine	0.44784	CHRNA2
439	N	N	N	N	Quinidine sulfate	KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 6	0.20548	Verapamil	0.57211	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
440	N	N	N	N	Diazoxide	MCOLN1: mucolipin 1	0.18518	Amiloride hydrochloride	0.032255	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
441	N	N	N	N	Ethotoin	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.36000	Phenytoin	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
442	N	Y	N	N	Felodipine	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.75862	Nitrendipine	0.13350	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
443	N	N	N	N	Amlexanox	ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9	0.27907	Verapamil	0.68192	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
444	N	N	N	N	Procaine hydrochloride	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.57895	Benzocaine	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
445	N	N	N	N	Diazoxide	TRPC6: transient receptor potential cation channel, subfamily C, member 6	0.18518	Amiloride hydrochloride	0.027859	KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
446	N	N	N	N	Proline	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.19048	Methylphenidate	0.41013	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
447	N	Y	N	N	Felodipine	CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit	0.75862	Nitrendipine	0.58498	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
448	Y	N	N	N	Haloperidol	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.52632	Cisapride	0.014090	GRIN2C: glutamate receptor, ionotropic, N-methyl D-aspartate 2C
449	N	N	N	N	Quinidine sulfate	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.16667	Cocaine	0.46734	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
450	N	N	N	N	Glipizide	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.77778	Glyburide	0.014445	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
451	N	N	N	N	Propafenone hydrochloride	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.34091	Verapamil	0.55968	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
452	N	N	N	N	Methoxyflurane	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.17647	Flecainide acetate	0.79208	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
453	N	N	N	N	Dextromethorphan	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.42308	Ketamine hydrochloride	0.44349	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
454	N	N	N	N	Amiodarone hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.58333	Dibucaine	0.025844	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
455	N	N	N	N	Quinidine gluconate	KCNA6: potassium voltage-gated channel, shaker-related subfamily, member 6	0.18644	Verapamil	0.57211	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
456	N	N	N	N	Dopamine hydrochloride	GLRA3	0.21429	Tropisetron hydrochloride	0.095753	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
457	N	N	Y	N	Amlodipine maleate	CACNA1B: calcium channel, voltage-dependent, N type, alpha 1B subunit	0.48837	Nisoldipine	0.58498	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
458	N	N	N	N	Levetiracetam	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.30769	Dyclonine hydrochloride	0.60301	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
459	N	N	N	N	Levobupivacaine hydrochloride	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.95652	Bupivacaine hydrochloride	0.027135	KCNK5: potassium channel, subfamily K, member 5
460	N	N	Y	N	Butabarbital	GABRA2	0.82353	Pentobarbital	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
461	N	N	N	N	Fluphenazine hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.44737	Fluoxetine hydrochloride	0.55275	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
462	N	N	N	N	Verapamil	P2RX7: purinergic receptor P2X, ligand-gated ion channel, 7	0.17500	Caffeine	0.027427	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
463	N	N	N	N	Nicotine bitartrate	KCND2: potassium voltage-gated channel, Shal-related subfamily, member 2	0.11628	Diazoxide	0.74853	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
464	N	N	N	N	Guanethidine sulfate	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.17778	Dextromethorphan	0.49354	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
465	N	N	N	N	Sevoflurane	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.25714	Flecainide acetate	0.79208	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
466	N	N	N	N	Ondansetron hydrochloride hydrate	GLRA3	0.34286	Tropisetron hydrochloride	0.095753	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
467	N	N	N	N	Quinidine sulfate	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.31884	Ketoconazole	0.54502	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
468	N	N	N	N	Trifluoperazine maleate	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.45833	Thioridazine hydrochloride	0.030674	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
469	N	N	N	N	Thioridazine	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.54054	Fluphenazine hydrochloride	0.024221	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
470	N	N	N	N	Benzocaine	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.31034	Nitrendipine	0.12677	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
471	N	N	N	N	Diltiazem hydrochloride	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2	0.39130	Verapamil hydrochloride	0.63973	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
472	N	N	N	N	Metocurine iodide	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.67619	Tubocurarine chloride	0.077681	CHRNA2
473	N	N	N	N	Ibutilide fumarate	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8	0.29167	Verapamil	0.66902	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
474	N	N	N	N	Benzocaine	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.31034	Nitrendipine	0.12915	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
475	N	N	N	N	Amlodipine maleate	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.48837	Nisoldipine	0.51802	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
476	N	N	N	N	Granisetron hydrochloride	GLRA2: glycine receptor, alpha 2	0.53333	Tropisetron hydrochloride	0.10113	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
477	N	N	N	N	Proline	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.16667	Dextromethorphan	0.38489	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
478	N	N	N	N	Diazoxide	GRIK1: glutamate receptor, ionotropic, kainate 1	0.38095	Riluzole	0.34713	GRIA1: glutamate receptor, ionotropic, AMPA 1
479	N	N	N	N	Trimethadione	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.28571	Hexobarbital	0.0087226	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
480	Y	Y	N	N	Cyclothiazide	GRIA4: glutamate receptor, ionotropic, AMPA 4	0.26667	Diazoxide	0.73920	GRIA2: glutamate receptor, ionotropic, AMPA 2
481	N	N	N	N	Quinidine gluconate	KCNK17: potassium channel, subfamily K, member 17	0.18644	Verapamil	0.34803	KCNK16: potassium channel, subfamily K, member 16
482	N	N	N	N	Tropisetron hydrochloride	GABRR2	0.35484	Diazepam	0.29902	GLRA2: glycine receptor, alpha 2
483	N	N	N	Y	Carbamazepine	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.40000	Moricizine hydrochloride	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
484	N	N	N	Y	Mecamylamine hydrochloride	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.20000	Carbachol	0.31221	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
485	N	N	N	N	Terfenadine	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.27114	Verapamil	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
486	N	N	N	N	Dantrolene	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.41935	Clobazam	0.0064074	RYR1: ryanodine receptor 1 (skeletal)
487	N	N	N	N	Cetiedil citrate	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.20690	Glyburide	0.010929	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
488	N	N	N	N	Flecainide acetate	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.27027	Riluzole	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
489	N	N	N	N	Verapamil hydrochloride	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.97059	Verapamil	0.14611	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
490	N	N	N	N	Disopyramide	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.34884	Verapamil	0.13120	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
491	N	N	N	Y	Tocainide	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.93333	Tocainide hydrochloride	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
492	N	N	N	N	Ketoconazole	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.40816	Glyburide	0.011075	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
493	N	N	N	N	Levobupivacaine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.95652	Bupivacaine hydrochloride	0.021715	KCNK5: potassium channel, subfamily K, member 5
494	Y	Y	N	N	Cyclothiazide	GRIA3: glutamate receptor, ionotropic, AMPA 3	0.26667	Diazoxide	0.73123	GRIA2: glutamate receptor, ionotropic, AMPA 2
495	N	N	N	N	Diazoxide	SCN4B: sodium channel, voltage-gated, type IV, beta subunit	0.40000	Zonisamide	0.044678	KCNE1: potassium voltage-gated channel, Isk-related family, member 1
496	N	N	N	N	Metocurine iodide	CHRNA5: cholinergic receptor, nicotinic, alpha 5 (neuronal)	0.67619	Tubocurarine chloride	0.44323	CHRNA2
497	N	N	N	N	Verapamil hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.97059	Verapamil	0.12559	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
498	N	N	N	N	Quinidine gluconate	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.20408	Cocaine	0.46734	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
499	N	N	N	N	Thioridazine hydrochloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.64706	Trifluoperazine hydrochloride	0.030674	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
500	N	N	N	N	Halazepam	GLRA1: glycine receptor, alpha 1	0.76000	Diazepam	0.31459	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
501	N	N	N	N	Cetiedil citrate	CHRNA2	0.33962	Nicotine bitartrate	0.019239	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
502	N	N	N	N	Quinidine sulfate	KCNK17: potassium channel, subfamily K, member 17	0.20548	Verapamil	0.34803	KCNK16: potassium channel, subfamily K, member 16
503	N	N	N	N	Riluzole	GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 1	0.23077	Ketamine hydrochloride	0.15710	GRIK1: glutamate receptor, ionotropic, kainate 1
504	N	N	N	N	Ibutilide fumarate	CACNB3: calcium channel, voltage-dependent, beta 3 subunit	0.29167	Verapamil	0.49490	CACNB1: calcium channel, voltage-dependent, beta 1 subunit
505	N	N	N	N	Procaine hydrochloride	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.33333	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
506	N	N	N	N	Verapamil	P2RX5: purinergic receptor P2X, ligand-gated ion channel, 5	0.17500	Caffeine	0.045889	KCNE1L: KCNE1-like
507	N	N	N	N	Chlorothiazide	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.51852	Cyclothiazide	0.010212	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
508	N	N	N	N	Tolazamide	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8	0.25000	Diazoxide	0.66902	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
509	N	N	N	N	Quinine hydrochloride hydrate	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.29546	Diltiazem hydrochloride	0.66887	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
510	N	N	N	Y	Pentobarbital calcium	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2	0.40000	Pentobarbital	0.43368	GABRA6
511	N	Y	N	N	Felodipine	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.75862	Nitrendipine	0.10257	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
512	N	Y	N	N	Felbamate	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.19444	Haloperidol	0.44349	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
513	N	N	N	N	Flecainide acetate	KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 4	0.20370	Verapamil	0.64803	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
514	N	N	N	Y	Prilocaine	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.94118	Prilocaine hydrochloride	0.60341	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
515	N	N	Y	N	Verapamil hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.97059	Verapamil	0.11951	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
516	N	N	N	N	Disopyramide	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.34884	Verapamil	0.13386	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
517	N	N	N	N	Mefloquine hydrochloride	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.31250	Riluzole	0.011082	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
518	N	N	N	N	Glyburide	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.40816	Ketoconazole	0.017942	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
519	N	N	N	N	Loratadine	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.32558	Diltiazem hydrochloride	0.55968	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
520	N	N	N	N	Diazepam	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.30769	Diazoxide	0.018959	GLRA1: glycine receptor, alpha 1
521	N	N	N	N	Gallopamil hydrochloride	CACNG1: calcium channel, voltage-dependent, gamma subunit 1	0.86486	Verapamil	0.012500	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
522	N	N	N	Y	Tubocurarine chloride	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.16364	Nicotine	0.31221	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
523	N	N	N	N	Amlodipine besylate	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.57447	Nicardipine hydrochloride	0.020088	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
524	Y	N	Y	Y	Repaglinide	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.43478	Glyburide	0.013742	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
525	N	N	N	N	Ibutilide fumarate	KCNK16: potassium channel, subfamily K, member 16	0.29167	Verapamil	0.24996	KCNK6: potassium channel, subfamily K, member 6
526	N	N	N	N	Bupivacaine hydrochloride	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.34146	Flecainide acetate	0.55968	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
527	N	N	N	N	Zonisamide	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.40000	Diazoxide	0.016547	SCN1B: sodium channel, voltage-gated, type I, beta subunit
528	N	N	N	N	Verapamil	P2RX3: purinergic receptor P2X, ligand-gated ion channel, 3	0.17500	Caffeine	0.030341	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
529	N	N	N	Y	Tolazamide	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.56000	Tolbutamide	0.013742	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
530	N	N	N	N	Mepivacaine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.75000	Bupivacaine hydrochloride	0.026637	KCNK5: potassium channel, subfamily K, member 5
531	N	N	N	N	Exemestane	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.18750	Pentobarbital	0.31850	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
532	N	N	N	N	Encainide hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.65625	Thioridazine hydrochloride	0.016835	SCN2A: sodium channel, voltage-gated, type II, alpha subunit
533	N	N	N	N	Amlodipine maleate	CACNG1: calcium channel, voltage-dependent, gamma subunit 1	0.48837	Nisoldipine	0.018083	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
534	N	N	N	N	Verapamil hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.97059	Verapamil	0.032967	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
535	N	N	N	N	Halazepam	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.39286	Riluzole	0.011445	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
536	N	N	N	Y	Moricizine	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.96774	Moricizine hydrochloride	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
537	N	N	N	N	Amlodipine besylate	CACNG1: calcium channel, voltage-dependent, gamma subunit 1	0.48837	Nitrendipine	0.018083	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
538	N	N	N	N	Metoclopramide	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.56000	Chloroprocaine hydrochloride	0.013456	CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)
539	N	N	N	N	Verapamil	P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6	0.17500	Caffeine	0.029220	KCNE3: potassium voltage-gated channel, Isk-related family, member 3
540	N	N	N	N	Halofantrine hydrochloride	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.36735	Verapamil	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
541	N	N	Y	N	Zonisamide	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.16129	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
542	Y	N	Y	N	Sertraline	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.53846	Mazindol	0.48799	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
543	N	N	N	N	Chloroprocaine hydrochloride	RYR2: ryanodine receptor 2 (cardiac)	0.85000	Procaine hydrochloride	0.0081086	KCNK5: potassium channel, subfamily K, member 5
544	N	N	N	N	Diazoxide	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.25926	Metoclopramide	0.029958	KCNE3: potassium voltage-gated channel, Isk-related family, member 3
545	N	N	N	N	Benoxinate hydrochloride	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.80000	Proparacaine hydrochloride	0.51890	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
546	N	N	N	N	Dequalinium chloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.34783	Thioridazine hydrochloride	0.032967	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
547	N	N	N	N	Verapamil	GABRR2	0.30233	Zaleplon	0.030883	KCNE1L: KCNE1-like
548	N	N	N	N	Flecainide acetate	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2	0.22222	Verapamil hydrochloride	0.63973	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
549	N	N	N	N	Isoflurane	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.23529	Flecainide acetate	0.79208	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
550	N	N	N	N	Fluoxetine hydrochloride	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.34091	Ketoconazole	0.34860	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
551	N	N	N	Y	Disopyramide	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.45714	Propafenone hydrochloride	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
552	N	N	N	N	Chloroprocaine hydrochloride	RYR3	0.85000	Procaine hydrochloride	0.0065468	KCNK5: potassium channel, subfamily K, member 5
553	N	N	N	N	Metoclopramide	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.72727	Procainamide hydrochloride	0.015351	CHRNA4: cholinergic receptor, nicotinic, alpha 4 (neuronal)
554	N	N	N	N	Levetiracetam	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.30769	Dyclonine hydrochloride	0.83065	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
555	N	N	N	N	Mefloquine hydrochloride	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.47500	Flecainide acetate	0.081115	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
556	N	N	N	N	Verapamil hydrochloride	KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 5	0.97059	Verapamil	0.70666	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
557	N	N	N	N	Methoxyflurane	GLRA3	0.071429	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
558	N	N	N	N	Alprazolam	GLRA2: glycine receptor, alpha 2	0.68000	Diazepam	0.32569	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
559	N	N	N	N	Verapamil hydrochloride	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.97059	Verapamil	0.035140	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
560	N	N	N	N	Pramoxine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.38461	Flecainide acetate	0.026637	KCNK5: potassium channel, subfamily K, member 5
561	N	N	Y	Y	Nateglinide	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8	0.36585	Glyburide	0.013742	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
562	N	N	N	N	Fluoxetine	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.34884	Ketoconazole	0.34860	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
563	N	N	N	N	Verapamil	P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1	0.17500	Caffeine	0.045455	KCNE3: potassium voltage-gated channel, Isk-related family, member 3
564	N	N	N	N	Exemestane	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.34483	Hexobarbital	0.090264	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
565	N	N	N	N	Riluzole	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.38095	Diazoxide	0.025836	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit
566	N	N	N	N	Dofetilide	KCNK16: potassium channel, subfamily K, member 16	0.40909	Verapamil	0.27152	KCNK2: potassium channel, subfamily K, member 2
567	N	N	N	N	Terfenadine	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.27114	Verapamil	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
568	N	N	N	Y	Topiramate	GRIK5: glutamate receptor, ionotropic, kainate 5	0.15152	Kainic acid hydrate	0.37570	GRIK1: glutamate receptor, ionotropic, kainate 1
569	N	N	N	N	Verapamil hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.97059	Verapamil	0.032538	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
570	N	N	Y	N	Magnesium sulfate	CACNB2: calcium channel, voltage-dependent, beta 2 subunit	0.027027	Nifedipine	0.015801	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
571	N	N	N	N	Bupivacaine hydrochloride	KCND2: potassium voltage-gated channel, Shal-related subfamily, member 2	0.19355	Diazoxide	0.74853	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
572	N	N	N	N	Ketamine hydrochloride	GABRG3	0.37500	Flurazepam	0.40101	GABRA6
573	N	N	N	N	Tolbutamide	ABCC9: ATP-binding cassette, sub-family C (CFTR/MRP), member 9	0.18605	Verapamil	0.68192	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
574	N	N	N	N	Tropisetron hydrochloride	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.39286	Ketamine hydrochloride	0.32323	GLRA3
575	N	N	N	N	Profenamine hydrochloride	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.37143	Dizocilpine maleate	0.44349	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
576	N	N	N	N	Desflurane	GABRA2	1	Isoflurane	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
577	N	N	N	N	Cyproheptadine hydrochloride	CHRNA2	0.39317	Tubocurarine chloride	0.018097	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
578	N	N	N	N	Ketoconazole	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.25455	Verapamil	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
579	N	N	N	N	Enflurane	GLRA3	0.032258	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
580	N	N	N	N	Diltiazem malate	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2	0.33962	Verapamil	0.63973	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
581	N	N	N	N	Zonisamide	CACNA1E: calcium channel, voltage-dependent, R type, alpha 1E subunit	0.22222	Phenytoin	0.12631	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
582	N	N	N	N	Dofetilide	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.41026	Benzthiazide	0.022874	KCNK2: potassium channel, subfamily K, member 2
583	N	N	N	N	Ibutilide fumarate	KCNK2: potassium channel, subfamily K, member 2	0.41270	Dofetilide	0.20401	KCNK1: potassium channel, subfamily K, member 1
584	N	N	N	N	Isradipine	CACNG7: calcium channel, voltage-dependent, gamma subunit 7	0.66667	Nisoldipine	0.094539	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
585	N	Y	Y	N	Felodipine	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.75862	Nitrendipine	0.11063	CACNA1F: calcium channel, voltage-dependent, L type, alpha 1F subunit
586	N	N	N	N	Chloroprocaine hydrochloride	RYR1: ryanodine receptor 1 (skeletal)	0.85000	Procaine hydrochloride	0.0085784	KCNK5: potassium channel, subfamily K, member 5
587	N	N	N	N	Methylphenidate	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.56000	Cocaine	0.012733	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
588	N	N	N	Y	Tubocurarine chloride	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.16129	Metoclopramide	0.34687	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
589	N	N	N	Y	Topiramate	GRIK4: glutamate receptor, ionotropic, kainate 4	0.15152	Kainic acid hydrate	0.36616	GRIK1: glutamate receptor, ionotropic, kainate 1
590	N	N	N	N	Diazoxide	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.25926	Metoclopramide	0.035142	KCNK4: potassium channel, subfamily K, member 4
591	N	N	N	N	Procainamide hydrochloride	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.72727	Metoclopramide	0.010863	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
592	N	N	N	N	Nicotine bitartrate	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.35294	Nicotine	0.31221	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
593	N	N	N	N	Carbamazepine	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.17647	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
594	N	N	N	Y	Topiramate	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.20000	Mexiletine hydrochloride	0.83065	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
595	N	N	N	N	Ethchlorvynol	GLRA1: glycine receptor, alpha 1	0.21429	Methoxyflurane	0.31459	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
596	N	N	N	N	Magnesium sulfate	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.10345	Glyclopyramide	0.025831	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
597	N	N	N	N	Tocainide	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.63158	Lidocaine	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
598	N	N	N	Y	Disopyramide	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.45714	Propafenone hydrochloride	0.72659	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
599	N	N	N	N	Ropivacaine hydrochloride	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.87500	Bupivacaine hydrochloride	0.027135	KCNK5: potassium channel, subfamily K, member 5
600	N	N	N	N	Letrozole	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.34884	Ketoconazole	0.017956	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
601	N	N	N	N	Gallopamil hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.86486	Verapamil	0.0096347	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
602	N	N	N	N	Cisapride	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.35417	Verapamil	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
603	N	N	N	N	Tubocurarine chloride	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.30378	Ketoconazole	0.34860	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
604	N	N	N	N	Granisetron	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.48387	Nateglinide	0.017658	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
605	N	N	N	N	Aminoglutethimide	CHRNA2	0.32000	Pentobarbital	0.44784	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
606	N	N	N	N	Diazoxide	SCN3B: sodium channel, voltage-gated, type III, beta subunit	0.40000	Zonisamide	0.046014	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
607	N	N	N	N	Isradipine	TRPV6: transient receptor potential cation channel, subfamily V, member 6	0.66667	Nisoldipine	0.019119	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
608	N	Y	N	N	Felbamate	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.40000	Etomidate	0.31643	GLRA2: glycine receptor, alpha 2
609	N	N	N	N	Gallopamil hydrochloride	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.86486	Verapamil	0.023214	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
610	N	N	N	N	Dequalinium chloride	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.40000	Halofantrine hydrochloride	0.017196	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1
611	N	N	N	N	Profenamine hydrochloride	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.56250	Flurazepam	0.011071	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
612	N	N	N	N	Furosemide	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2	0.32258	Diazepam	0.43368	GABRA6
613	N	N	N	N	Glipizide	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8	0.25000	Diazoxide	0.66902	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
614	N	N	N	Y	Tocainide	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.93333	Tocainide hydrochloride	0.60341	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
615	N	N	N	N	Cisapride	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.34694	Verapamil	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
616	N	N	N	N	Midazolam	GLRB: glycine receptor, beta	0.59259	Diazepam	0.29609	GABRB1
617	N	N	N	N	Prilocaine	KCNK5: potassium channel, subfamily K, member 5	0.94118	Prilocaine hydrochloride	0.010777	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
618	N	N	N	N	Quinine hydrochloride hydrate	KCNB1: potassium voltage-gated channel, Shab-related subfamily, member 1	0.24242	Diazoxide	0.58646	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
619	N	N	N	Y	Cocaine	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.33333	Procaine hydrochloride	0.60301	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
620	N	N	N	N	Diazepam	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.38889	Diltiazem hydrochloride	0.019626	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
621	N	N	N	N	Butabarbital	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.82353	Pentobarbital	0.072378	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
622	N	N	N	N	Isradipine	TRPA1: transient receptor potential cation channel, subfamily A, member 1	0.66667	Nisoldipine	0.015142	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
623	N	N	Y	N	Nimodipine	CACNB4: calcium channel, voltage-dependent, beta 4 subunit	0.75000	Nitrendipine	0.54913	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
624	N	N	N	N	Fluoxetine	KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 5	0.34146	Verapamil	0.70666	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
625	N	N	N	Y	Benzocaine	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.57895	Procaine hydrochloride	0.86296	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
626	N	N	N	N	Diazoxide	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.16129	Cocaine	0.026833	KCND2: potassium voltage-gated channel, Shal-related subfamily, member 2
627	N	N	N	N	Promethazine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.56667	Thioridazine hydrochloride	0.024221	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
628	N	N	N	N	Proline	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.19048	Methylphenidate	0.40340	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7
629	N	N	Y	N	Butabarbital	GABRA5: gamma-aminobutyric acid (GABA) A receptor, alpha 5	0.82353	Pentobarbital	0.69495	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
630	N	N	N	N	Granisetron hydrochloride	GLRA1: glycine receptor, alpha 1	0.53333	Tropisetron hydrochloride	0.098396	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
631	N	N	N	N	Benoxinate hydrochloride	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.80000	Proparacaine hydrochloride	0.54531	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
632	N	N	N	N	Ropivacaine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.87500	Bupivacaine hydrochloride	0.021715	KCNK5: potassium channel, subfamily K, member 5
633	N	N	N	N	Benzocaine	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.31034	Nitrendipine	0.13951	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
634	N	N	N	N	Desipramine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.51613	Thioridazine hydrochloride	0.024221	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
635	N	N	N	N	Benoxinate hydrochloride	KCNK5: potassium channel, subfamily K, member 5	0.70833	Procaine hydrochloride	0.011241	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
636	N	N	N	N	Butabarbital	CHRNA2	0.82353	Pentobarbital	0.077681	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
637	N	N	N	N	Verapamil	P2RX4: purinergic receptor P2X, ligand-gated ion channel, 4	0.17500	Caffeine	0.033352	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
638	N	N	N	N	Phencyclidine hydrochloride	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.40909	Nicotine	0.31221	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
639	N	N	N	N	Magnesium sulfate	CACNA2D2: calcium channel, voltage-dependent, alpha 2/delta subunit 2	0.027027	Nifedipine	0.52208	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1
640	N	N	N	N	Halofantrine hydrochloride	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.36735	Verapamil	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
641	N	N	N	N	Diazoxide	SCN1B: sodium channel, voltage-gated, type I, beta subunit	0.40000	Zonisamide	0.045507	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
642	N	N	N	N	Benoxinate hydrochloride	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.80000	Proparacaine hydrochloride	0.53503	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
643	N	N	N	N	Methoxyflurane	KCNK13: potassium channel, subfamily K, member 13	0.66667	Halothane	0.027455	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
644	N	N	N	N	Methoxyflurane	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.66667	Halothane	0.031390	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
645	N	N	N	N	Quinine hydrochloride hydrate	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.60000	Quinidine gluconate	0.56382	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
646	N	N	N	N	Fluphenazine maleate	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.36364	Fluoxetine	0.55275	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
647	N	N	N	N	Halofantrine hydrochloride	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.38636	Flurazepam	0.012494	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
648	N	N	N	N	Letrozole	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.13333	Nicotine	0.31850	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
649	N	N	N	N	Phentermine	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.38889	Mexiletine hydrochloride	0.010278	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
650	N	N	N	N	Dyclonine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.45161	Bupivacaine hydrochloride	0.026637	KCNK5: potassium channel, subfamily K, member 5
651	N	N	N	N	Diazoxide	P2RX2: purinergic receptor P2X, ligand-gated ion channel, 2	0.21739	Caffeine	0.042682	KCNK4: potassium channel, subfamily K, member 4
652	N	N	N	N	Verapamil hydrochloride	KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 9	0.97059	Verapamil	0.68294	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
653	N	N	N	Y	Moricizine	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.96774	Moricizine hydrochloride	0.60341	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
654	N	N	N	N	Verapamil hydrochloride	CACNG1: calcium channel, voltage-dependent, gamma subunit 1	0.97059	Verapamil	0.024826	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
655	N	N	N	N	Metocurine iodide	CHRNA9: cholinergic receptor, nicotinic, alpha 9 (neuronal)	0.67619	Tubocurarine chloride	0.31065	CHRNA2
656	N	N	N	N	Nateglinide	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.44828	Mepivacaine hydrochloride	0.0099976	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
657	N	N	N	N	Gallopamil hydrochloride	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.86486	Verapamil	0.0077683	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
658	N	N	N	N	Kainic acid hydrate	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.043478	Methoxyflurane	0.35409	GRIK2: glutamate receptor, ionotropic, kainate 2
659	N	N	N	N	Dextromethorphan	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)	0.53571	Codeine	0.52424	CHRNA2
660	N	N	N	N	Methohexital	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.59091	Pentobarbital	0.090264	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
661	N	N	N	N	Verapamil hydrochloride	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.97059	Verapamil	0.13105	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
662	N	N	N	N	Tubocurarine chloride	GABRE: gamma-aminobutyric acid (GABA) A receptor, epsilon	0.23975	Midazolam	0.33697	GABRA6
663	N	N	N	N	Repaglinide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.37650	Glipizide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
664	N	N	N	N	Riluzole	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.26923	Amiloride hydrochloride	0.13120	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
665	N	N	N	N	Metocurine iodide	CHRNA1: cholinergic receptor, nicotinic, alpha 1 (muscle)	0.67619	Tubocurarine chloride	0.42204	CHRNA2
666	N	N	N	N	Diltiazem hydrochloride	KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 4	0.36956	Verapamil	0.64803	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
667	N	N	N	N	Bepridil hydrochloride	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.45714	Trimipramine	0.014048	KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
668	N	N	N	N	Gliclazide	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8	0.24138	Diazoxide	0.66902	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
669	N	N	N	N	Disopyramide	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.34884	Verapamil	0.13951	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
670	N	N	N	Y	Minoxidil	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.28571	Tolazamide	0.39373	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
671	N	N	N	N	Ketoconazole	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.25455	Verapamil	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
672	N	N	N	N	Flurazepam	GLRA2: glycine receptor, alpha 2	0.62069	Diazepam	0.32569	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
673	N	N	N	N	Enoxacin hydrate	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2	0.22500	Flurazepam	0.43368	GABRA6
674	N	N	N	N	Gallopamil hydrochloride	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1	0.86486	Verapamil	0.0064963	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
675	N	N	N	N	Thiamylal	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.65000	Pentobarbital	0.090264	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
676	N	N	N	N	Quinine sulfate	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.20779	Diltiazem malate	0.66887	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
677	N	N	N	N	Anastrozole	CHRNA2	0.23529	Metoclopramide	0.44784	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
678	N	N	N	N	Moricizine	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.41176	Carbamazepine	0.60410	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
679	N	N	N	N	Penicillin G procaine	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2	0.38776	Flurazepam	0.43368	GABRA6
680	N	N	N	N	Phenacemide	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.40000	Tocainide hydrochloride	0.63042	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
681	N	N	N	N	Flecainide acetate	KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 3	0.20370	Verapamil	0.57702	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
682	N	N	N	N	Amlexanox	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.38710	Furosemide	0.010906	ABCC8: ATP-binding cassette, sub-family C (CFTR/MRP), member 8
683	N	N	N	N	Benzocaine	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.45000	Felbamate	0.022827	SCN4B: sodium channel, voltage-gated, type IV, beta subunit
684	N	N	N	N	Ketoconazole	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7	0.31884	Quinidine sulfate	0.54502	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
685	N	N	N	N	Phenacemide	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.38461	Nateglinide	0.011295	SCN1A: sodium channel, voltage-gated, type I, alpha subunit
686	N	N	N	N	Felodipine	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.56410	Nicardipine hydrochloride	0.020088	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
687	N	N	Y	N	Primidone	GABRA2	0.43478	Ketamine hydrochloride	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
688	N	N	N	N	Biperiden	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)	0.50000	Phencyclidine hydrochloride	0.52424	CHRNA2
689	N	N	N	N	Methylphenidate	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	0.19048	Proline	0.41013	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
690	N	N	N	N	Quinine sulfate	KCNK5: potassium channel, subfamily K, member 5	1	Quinidine sulfate	0.028410	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
691	N	N	N	N	Mefloquine hydrochloride	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.31707	Bendroflumethiazide	0.022575	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
692	N	N	N	N	Metocurine iodide	CHRNA10	0.67619	Tubocurarine chloride	0.30303	CHRNA2
693	N	N	N	N	Isradipine	CACNG2: calcium channel, voltage-dependent, gamma subunit 2	0.66667	Nisoldipine	0.093335	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
694	N	N	N	N	Ketoconazole	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	0.32000	Diltiazem hydrochloride	0.53242	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
695	N	N	N	N	Diazoxide	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.40000	Zonisamide	0.030864	KCNV1: potassium channel, subfamily V, member 1
696	N	N	N	N	Quinidine gluconate	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.25862	Ketoconazole	0.54502	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
697	N	N	N	N	Mitiglinide calcium hydrate	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8	0.15493	Verapamil	0.66902	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
698	N	N	Y	N	Magnesium sulfate	CACNB1: calcium channel, voltage-dependent, beta 1 subunit	0.042857	Ibutilide fumarate	0.016265	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
699	N	N	N	N	Glyclopyramide	KCNJ8: potassium inwardly-rectifying channel, subfamily J, member 8	0.32000	Diazoxide	0.66902	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
700	N	N	N	N	Trichlormethiazide	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.62963	Cyclothiazide	0.010212	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
701	N	N	N	N	Loratadine	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	0.35000	Quinine hydrochloride hydrate	0.53491	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
702	N	N	N	N	Pentobarbital	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.16129	Metoclopramide	0.26265	CHRNA10
703	N	N	N	N	Codeine sulfate	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.39744	Quinine sulfate	0.015233	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
704	N	N	N	N	Verapamil	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.36585	Profenamine hydrochloride	0.023718	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
705	N	N	N	N	Paroxetine	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.27778	Cocaine	0.41406	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
706	N	N	N	N	Ketamine hydrochloride	GABRE	0.37500	Flurazepam	0.33697	GABRA6
707	N	N	N	N	Disopyramide	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.20513	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
708	N	N	N	N	Mefloquine hydrochloride	GLRA1: glycine receptor, alpha 1	0.32432	Tropisetron hydrochloride	0.015107	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
709	N	Y	N	N	Felbamate	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.18518	Riluzole	0.092521	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
710	N	N	Y	N	Butabarbital	GABRA3: gamma-aminobutyric acid (GABA) A receptor, alpha 3	0.82353	Pentobarbital	0.66731	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
711	N	N	N	Y	Dibucaine	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	0.48276	Procainamide hydrochloride	0.60301	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
712	N	N	N	N	Gabapentin	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.20833	Ketamine hydrochloride	0.44349	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
713	N	N	N	N	Azimilide dihydrochloride	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.38636	Flurazepam	0.015344	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
714	N	N	N	N	Verapamil hydrochloride	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.97059	Verapamil	0.39592	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
715	N	N	N	N	Hydroflumethiazide	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.51724	Cyclothiazide	0.010212	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
716	N	N	N	N	Ethchlorvynol	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.21429	Methoxyflurane	0.011445	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
717	N	N	N	Y	Pentobarbital calcium	GABRG3	0.40000	Pentobarbital	0.40101	GABRA6
718	N	N	N	N	Phencyclidine hydrochloride	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.40909	Nicotine	0.26265	CHRNA10
719	N	N	N	N	Fluoxetine hydrochloride	KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 5	0.33333	Verapamil	0.70666	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
720	N	N	N	N	Quinine sulfate	KCNB1: potassium voltage-gated channel, Shab-related subfamily, member 1	0.20548	Verapamil	0.58646	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
721	N	Y	Y	N	Felodipine	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1	0.75862	Nitrendipine	0.0064963	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
722	N	N	N	N	Verapamil	HTR3D: 5-hydroxytryptamine (serotonin) receptor 3D, ionotropic	0.23404	Ondansetron hydrochloride hydrate	0.042488	KCNMB1: potassium large conductance calcium-activated channel, subfamily M, beta member 1
723	Y	N	N	N	Paroxetine	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	0.46667	Mazindol	0.48799	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
724	Y	N	N	N	Phenytoin	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.56000	Oxazepam	0.025549	SCN4B: sodium channel, voltage-gated, type IV, beta subunit
725	N	N	N	N	Quinidine sulfate	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.20779	Diltiazem malate	0.59825	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
726	N	N	Y	N	Amlodipine besylate	CACNB2: calcium channel, voltage-dependent, beta 2 subunit	0.48837	Nitrendipine	0.017211	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
727	Y	N	N	Y	Carbamazepine	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.40000	Moricizine hydrochloride	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
728	N	N	N	N	Cisapride	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.35417	Verapamil	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
729	N	N	N	N	Profenamine hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.53125	Propafenone hydrochloride	0.0097377	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
730	N	N	N	N	Mirtazapine	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.51852	Maprotiline	0.018814	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
731	N	N	N	Y	Tubocurarine chloride	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.16129	Metoclopramide	0.33926	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
732	N	N	N	N	Amiodarone hydrochloride	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.40425	Verapamil hydrochloride	0.54502	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
733	N	N	N	N	Diazoxide	SLC6A14: solute carrier family 6 (amino acid transporter), member 14	0	Proline	0.033290	KCNK17: potassium channel, subfamily K, member 17
734	N	N	N	N	Diltiazem malate	KCNC4: potassium voltage-gated channel, Shaw-related subfamily, member 4	0.33962	Verapamil	0.64803	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
735	N	N	N	N	Cocaine	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.33333	Procaine hydrochloride	0.58865	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
736	Y	N	Y	Y	Desipramine hydrochloride	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.72000	Trimipramine	0.017087	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
737	N	N	N	N	Quinine hydrochloride hydrate	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.29546	Diltiazem hydrochloride	0.66583	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
738	N	N	N	N	Fluphenazine maleate	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.48837	Thioridazine hydrochloride	0.024221	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
739	N	N	N	N	Maprotiline	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.53333	Thioridazine	0.020826	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
740	N	N	N	N	Ethosuximide	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.44444	Pentobarbital	0.0094499	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
741	N	N	N	N	Cisapride	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.34694	Verapamil	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
742	N	N	N	N	Proparacaine hydrochloride	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.25714	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
743	N	N	N	Y	Cocaine	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.33333	Procaine hydrochloride	0.59648	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
744	N	N	N	N	Metocurine iodide	CHRNA7: cholinergic receptor, nicotinic, alpha 7 (neuronal)	0.67619	Tubocurarine chloride	0.34519	CHRNA2
745	N	N	N	N	Dopamine hydrochloride	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.35294	Chlorzoxazone	0.015696	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
746	N	N	N	N	Propafenone hydrochloride	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.34091	Verapamil	0.48532	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
747	N	N	Y	N	Nimodipine	CACNB3: calcium channel, voltage-dependent, beta 3 subunit	0.75000	Nitrendipine	0.48563	CACNB2: calcium channel, voltage-dependent, beta 2 subunit
748	N	N	N	N	Mefloquine hydrochloride	KCNE1: potassium voltage-gated channel, Isk-related family, member 1	0.24390	Indapamide	0.026945	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
749	N	N	N	N	Thioridazine hydrochloride	KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 5	0.34091	Verapamil	0.70666	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
750	N	N	N	N	Primidone	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.72222	Ethotoin	0.0092349	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
751	N	N	N	N	Diazoxide	GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 1	0.29167	Ketamine hydrochloride	0.14656	GRIA1: glutamate receptor, ionotropic, AMPA 1
752	N	N	N	N	Maprotiline	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.45714	Moricizine	0.0094747	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
753	N	N	N	N	Nicotine bitartrate	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.24490	Quinine hydrochloride hydrate	0.18777	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
754	N	N	N	N	Thioridazine	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.61765	Trifluoperazine hydrochloride	0.030674	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
755	N	N	N	N	Fluoxetine	KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 9	0.34146	Verapamil	0.68294	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
756	N	Y	N	N	Halothane	GABRA2	0.54546	Isoflurane	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
757	N	N	Y	N	Butabarbital	CHRNA4: cholinergic receptor, nicotinic, alpha 4 (neuronal)	0.82353	Pentobarbital	0.076957	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
758	N	N	N	N	Sumatriptan	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.36000	Diazoxide	0.015696	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
759	N	N	N	N	Isradipine	CACNG4: calcium channel, voltage-dependent, gamma subunit 4	0.66667	Nisoldipine	0.077119	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
760	N	N	N	N	Verapamil hydrochloride	KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 3	0.97059	Verapamil	0.47605	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
761	N	N	N	N	Dofetilide	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit	0.41270	Ibutilide fumarate	0.011007	KCNH5: potassium voltage-gated channel, subfamily H (eag-related), member 5
762	N	N	Y	N	Galantamine hydrobromide	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.25926	Nicotine	0.44784	CHRNA2
763	N	N	N	N	Terfenadine	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit	0.60465	Pimozide	0.0095753	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
764	N	N	Y	N	Quinidine sulfate	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.32836	Astemizole	0.22326	KCNH1: potassium voltage-gated channel, subfamily H (eag-related), member 1
765	N	N	Y	N	Amlodipine maleate	CACNB2: calcium channel, voltage-dependent, beta 2 subunit	0.48837	Nisoldipine	0.017211	CACNA1A: calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
766	N	N	N	N	Methoxyflurane	KCNK12: potassium channel, subfamily K, member 12	0.66667	Halothane	0.029641	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
767	N	N	N	N	Quinine sulfate	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.31884	Ketoconazole	0.53242	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
768	N	N	N	N	Mibefradil dihydrochloride	PKD1: polycystic kidney disease 1 (autosomal dominant)	0.44898	Verapamil	0.0049566	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
769	N	N	N	N	Thioridazine	KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 5	0.34884	Verapamil	0.70666	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
770	N	N	N	N	Diazoxide	P2RX7: purinergic receptor P2X, ligand-gated ion channel, 7	0.21739	Caffeine	0.027427	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
771	N	N	N	N	Physostigmine sulfate	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.17544	Anastrozole	0.44784	CHRNA2
772	N	N	N	N	Nortriptyline hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.48387	Dizocilpine maleate	0.024221	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
773	N	N	N	N	Methylphenidate	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.56000	Cocaine	0.012283	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
774	N	N	N	N	Mepivacaine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.75000	Bupivacaine hydrochloride	0.021715	KCNK5: potassium channel, subfamily K, member 5
775	N	N	N	N	Mibefradil dihydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.44898	Verapamil	0.13474	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
776	N	N	N	N	Diazoxide	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	0	Proline	0.031499	KCNK16: potassium channel, subfamily K, member 16
777	N	N	N	N	Propafenone hydrochloride	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1	0.34091	Verapamil	0.21997	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
778	N	N	N	N	Amlodipine besylate	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4	0.48837	Nitrendipine	0.0092209	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
779	N	N	N	N	Diazoxide	GLRA3	0.24138	Tropisetron hydrochloride	0.029733	KCNE1L: KCNE1-like
780	N	N	N	N	Phencyclidine hydrochloride	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.31250	Bupivacaine hydrochloride	0.18777	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
781	N	N	N	N	Dopamine hydrochloride	GLRA2: glycine receptor, alpha 2	0.26087	Felbamate	0.10113	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
782	N	N	N	N	Dextromethorphan	CHRNA6: cholinergic receptor, nicotinic, alpha 6 (neuronal)	0.53571	Codeine	0.49191	CHRNA2
783	N	N	N	N	Mazindol	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.53846	Diazepam	0.016836	SLC6A3: solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
784	N	N	N	N	Bupivacaine hydrochloride	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.28571	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
785	N	N	N	Y	Thiamylal	GABRA2	0.65000	Pentobarbital	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
786	N	N	N	N	Nicotine bitartrate	KCND1: potassium voltage-gated channel, Shal-related subfamily, member 1	0.11628	Diazoxide	0.62617	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
787	N	N	N	Y	Carbamazepine	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.40000	Moricizine hydrochloride	0.72659	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
788	N	N	N	N	Lamotrigine	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.35000	Chlorzoxazone	0.011633	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
789	N	N	N	N	Tetracaine hydrochloride	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.31250	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
790	N	N	N	N	Diazoxide	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.16129	Cocaine	0.027170	KCNF1: potassium voltage-gated channel, subfamily F, member 1
791	N	N	N	N	Penfluridol	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.48333	Trifluoperazine hydrochloride	0.011237	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
792	N	N	N	N	Desflurane	GLRA3	0.032258	Tropisetron hydrochloride	0.83309	GLRA1: glycine receptor, alpha 1
793	N	N	N	N	Biperiden	CHRNA6: cholinergic receptor, nicotinic, alpha 6 (neuronal)	0.50000	Phencyclidine hydrochloride	0.49191	CHRNA2
794	N	N	N	N	Paroxetine	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.43590	Cisapride	0.013109	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
795	N	N	N	N	Butabarbital	CHRNA10	0.82353	Pentobarbital	0.086146	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
796	N	N	N	N	Astemizole	KCNH7: potassium voltage-gated channel, subfamily H (eag-related), member 7	0.28846	Verapamil	0.52729	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
797	N	N	N	N	Methylphenidate	SLC6A14: solute carrier family 6 (amino acid transporter), member 14	0.19048	Proline	0.38254	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
798	N	N	N	N	Zaleplon	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.37143	Disopyramide	0.013396	GABRE
799	N	N	N	N	Verapamil hydrochloride	CACNA2D1: calcium channel, voltage-dependent, alpha 2/delta subunit 1	0.97059	Verapamil	0.014097	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10
800	N	N	N	N	Isradipine	ITPR1: inositol 1,4,5-trisphosphate receptor, type 1	0.66667	Nisoldipine	0.0095944	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
801	N	N	N	N	Butabarbital	CHRNA9: cholinergic receptor, nicotinic, alpha 9 (neuronal)	0.82353	Pentobarbital	0.086245	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
802	N	N	N	N	Physostigmine sulfate	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.36986	Quinine sulfate	0.015233	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
803	N	N	N	N	Bupivacaine hydrochloride	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.29730	Disopyramide	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
804	N	Y	N	N	Lamotrigine	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.40909	Riluzole	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
805	N	N	N	N	Phencyclidine hydrochloride	KCNB1: potassium voltage-gated channel, Shab-related subfamily, member 1	0.17857	Diazoxide	0.58646	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
806	N	N	N	N	Propafenone hydrochloride	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.34091	Verapamil	0.55487	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
807	N	N	N	N	Diazoxide	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.38095	Riluzole	0.092521	GRIA1: glutamate receptor, ionotropic, AMPA 1
808	N	N	N	N	Diazoxide	ASIC1: acid-sensing (proton-gated) ion channel 1	0.18518	Amiloride hydrochloride	0.026659	KCNE1L: KCNE1-like
809	N	N	N	N	Dextromethorphan	CHRNA4: cholinergic receptor, nicotinic, alpha 4 (neuronal)	0.53571	Codeine	0.52847	CHRNA2
810	N	N	N	N	Cocaine	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.36000	Benzocaine	0.38926	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
811	N	N	N	N	Tolbutamide	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.50000	Procainamide hydrochloride	0.0099976	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
812	N	N	N	N	Nicardipine hydrochloride	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3	0.40425	Diltiazem hydrochloride	0.54817	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
813	N	N	N	N	Butabarbital	CHRNA6: cholinergic receptor, nicotinic, alpha 6 (neuronal)	0.82353	Pentobarbital	0.087197	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
814	N	N	N	N	Diltiazem hydrochloride	KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 3	0.36956	Verapamil	0.57702	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
815	N	N	N	N	Diazoxide	ASIC2: acid-sensing (proton-gated) ion channel 2	0.18518	Amiloride hydrochloride	0.027845	KCNE4: potassium voltage-gated channel, Isk-related family, member 4
816	N	N	N	Y	Bepridil hydrochloride	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.45454	Terfenadine	0.017204	KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
817	N	N	N	N	Dibucaine	KCNK5: potassium channel, subfamily K, member 5	0.44828	Lidocaine	0.011241	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
818	N	N	N	N	Procainamide hydrochloride	CHRNE: cholinergic receptor, nicotinic, epsilon (muscle)	0.72727	Metoclopramide	0.011727	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
819	N	N	N	N	Isradipine	ITPR3: inositol 1,4,5-trisphosphate receptor, type 3	0.66667	Nisoldipine	0.0092991	CACNG1: calcium channel, voltage-dependent, gamma subunit 1
820	N	N	N	N	Sertraline	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.48276	Midazolam	0.014964	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
821	N	N	N	N	Flecainide acetate	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.20000	Cocaine	0.46734	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
822	N	N	N	N	Mefloquine hydrochloride	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.30769	Halazepam	0.015344	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
823	N	N	N	N	Quinine hydrochloride hydrate	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.60000	Quinidine gluconate	0.54817	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
824	N	N	N	N	Amiodarone hydrochloride	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.58333	Dibucaine	0.023243	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
825	N	N	N	N	Fluphenazine hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.56757	Thioridazine hydrochloride	0.024221	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
826	N	N	N	N	Codeine	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.35294	Bupivacaine hydrochloride	0.020018	CHRNA10
827	N	N	N	N	Diltiazem hydrochloride	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.36956	Verapamil	0.22001	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
828	N	N	N	N	Verapamil hydrochloride	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.97059	Verapamil	0.034158	KCNC2: potassium voltage-gated channel, Shaw-related subfamily, member 2
829	N	N	N	N	Nicardipine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.40425	Diltiazem hydrochloride	0.48532	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4
830	N	N	N	N	Penicillin G procaine	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit	0.47676	Diltiazem malate	0.011266	GABRA5
831	N	N	N	N	Furosemide	GABRG3	0.32258	Diazepam	0.40101	GABRA6
832	N	N	N	N	Metocurine iodide	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.67619	Tubocurarine chloride	0.016970	CHRNA2
833	N	N	N	N	Gallopamil hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.86486	Verapamil	0.019162	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
834	N	N	N	N	Diazoxide	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.40000	Zonisamide	0.025826	KCNS2: potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
835	N	N	N	N	Verapamil hydrochloride	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.97059	Verapamil	0.047460	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
836	N	N	N	N	Bupivacaine hydrochloride	KCNA4: potassium voltage-gated channel, shaker-related subfamily, member 4	0.25532	Nicardipine hydrochloride	0.48532	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
837	N	N	N	N	Prilocaine hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.53846	Bupivacaine hydrochloride	0.026637	KCNK5: potassium channel, subfamily K, member 5
838	N	N	N	N	Ibutilide fumarate	KCNK10: potassium channel, subfamily K, member 10	0.29167	Verapamil	0.18687	KCNK1: potassium channel, subfamily K, member 1
839	N	N	N	N	Zonisamide	PKD1: polycystic kidney disease 1 (autosomal dominant)	0.22222	Phenytoin	0.012238	SCN1B: sodium channel, voltage-gated, type I, beta subunit
840	N	N	N	N	Sertraline	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.27273	Cocaine	0.41406	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
841	N	N	N	N	Methoxyflurane	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.66667	Halothane	0.048992	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)
842	N	N	N	N	Dizocilpine maleate	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.48387	Nortriptyline hydrochloride	0.024221	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
843	N	N	N	N	Amiodarone hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.42105	Fluoxetine	0.021769	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
844	N	N	Y	Y	Amiodarone hydrochloride	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.51744	Halofantrine hydrochloride	0.019642	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
845	N	N	N	N	Ketamine hydrochloride	GLRA3	0.39286	Tropisetron hydrochloride	0.32591	GABRA2
846	N	N	N	N	Butabarbital	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)	0.82353	Pentobarbital	0.070568	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
847	N	N	N	N	Galantamine hydrobromide	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.39394	Granisetron hydrochloride	0.26265	CHRNA10
848	N	N	N	N	Promethazine teoclate	RYR1: ryanodine receptor 1 (skeletal)	0.40476	Caffeine and sodium benzoate	0.0072515	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
849	N	N	N	N	Diazoxide	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.40000	Zonisamide	0.025645	KCNF1: potassium voltage-gated channel, subfamily F, member 1
850	N	N	N	N	Dyclonine hydrochloride	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.43333	Tolazamide	0.021462	KCNK5: potassium channel, subfamily K, member 5
851	N	N	N	N	Kainic acid hydrate	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.28125	Dizocilpine maleate	0.096106	GRIK2: glutamate receptor, ionotropic, kainate 2
852	N	N	N	N	Halothane	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.22222	Riluzole	0.69656	GRIA1: glutamate receptor, ionotropic, AMPA 1
853	N	N	N	N	Dizocilpine maleate	GRIK2: glutamate receptor, ionotropic, kainate 2	0.28125	Kainic acid hydrate	0.15526	GRIN1: glutamate receptor, ionotropic, N-methyl D-aspartate 1
854	N	N	N	N	Flurazepam	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.43750	Chloroprocaine hydrochloride	0.012903	GABRG2: gamma-aminobutyric acid (GABA) A receptor, gamma 2
855	N	N	N	N	Sumatriptan	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.40741	Tolbutamide	0.021953	HTR3E: 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
856	N	N	N	N	Amlodipine maleate	CACNA2D4: calcium channel, voltage-dependent, alpha 2/delta subunit 4	0.48837	Nisoldipine	0.0092209	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
857	N	N	N	N	Desflurane	GABRA5	1	Isoflurane	0.69495	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
858	N	N	N	Y	Flecainide acetate	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.34146	Bupivacaine hydrochloride	0.24349	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
859	N	N	N	N	Dizocilpine maleate	KCNJ5: potassium inwardly-rectifying channel, subfamily J, member 5	0.23404	Verapamil	0.70666	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
860	N	N	N	N	Diltiazem hydrochloride	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6	0.44444	Fluoxetine	0.022791	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
861	N	N	N	N	Carbamazepine	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.37037	Phenytoin	0.13120	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
862	N	N	N	N	Diazoxide	P2RX5: purinergic receptor P2X, ligand-gated ion channel, 5	0.21739	Caffeine	0.045889	KCNE1L: KCNE1-like
863	N	N	N	N	Profenamine hydrochloride	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	0.60714	Trimipramine	0.010907	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
864	N	N	Y	N	Halazepam	GABRA2	0.76000	Diazepam	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
865	N	N	N	N	Kainic acid hydrate	SLC6A14: solute carrier family 6 (amino acid transporter), member 14	0.33333	Proline	0.015453	GRIK4: glutamate receptor, ionotropic, kainate 4
866	N	N	N	Y	Pentobarbital calcium	GABRE	0.40000	Pentobarbital	0.33697	GABRA6
867	N	N	N	N	Sertraline	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.42308	Ketamine hydrochloride	0.010907	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
868	N	N	N	N	Gallopamil hydrochloride	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.86486	Verapamil	0.010388	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
869	N	N	N	N	Fluoxetine hydrochloride	KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 9	0.33333	Verapamil	0.68294	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
870	N	N	N	N	Thioridazine hydrochloride	KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 9	0.34091	Verapamil	0.68294	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
871	N	N	N	N	Indapamide	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.41026	Glipizide	0.027394	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
872	N	N	N	N	Flecainide acetate	GLRA1: glycine receptor, alpha 1	0.25714	Sevoflurane	0.019946	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2
873	N	N	N	N	Gabapentin	ASIC2: acid-sensing (proton-gated) ion channel 2	0.034483	Amiloride hydrochloride	0.48895	ASIC3: acid-sensing (proton-gated) ion channel 3
874	N	Y	N	N	Methohexital	GABRA2	0.59091	Pentobarbital	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
875	N	N	N	N	Glyclopyramide	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.37838	Cisapride	0.014705	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
876	N	N	N	N	Repaglinide	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.50000	Moricizine	0.0099976	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
877	N	N	N	N	Mibefradil dihydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.44898	Verapamil	0.13545	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
878	N	N	N	N	Promethazine teoclate	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.38636	Flurazepam	0.016138	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
879	N	N	N	N	Codeine	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.25000	Nicotine	0.44784	CHRNA2
880	N	N	N	N	Promethazine hydrochloride	KCNN1: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1	0.39024	Dequalinium chloride	0.55275	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
881	N	N	N	N	Hydroflumethiazide	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.45833	Riluzole	0.0091408	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
882	N	N	N	N	Bupivacaine hydrochloride	KCND1: potassium voltage-gated channel, Shal-related subfamily, member 1	0.19355	Diazoxide	0.62617	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
883	N	N	N	N	Halazepam	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.48387	Fluoxetine	0.016138	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
884	N	N	N	N	Diltiazem malate	KCNC3: potassium voltage-gated channel, Shaw-related subfamily, member 3	0.33962	Verapamil	0.57702	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1
885	N	N	N	N	Nifedipine	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.38235	Cocaine	0.13474	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit
886	N	N	N	N	Caffeine	CLCN2: chloride channel, voltage-sensitive 2	0.051282	Lubiprostone	0.013935	P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1
887	N	N	N	N	Trichlormethiazide	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.40000	Riluzole	0.0091408	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
888	N	N	Y	N	Verapamil hydrochloride	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.97059	Verapamil	0.10064	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
889	N	N	N	N	Trifluoperazine hydrochloride	GRIA1: glutamate receptor, ionotropic, AMPA 1	0.32353	Riluzole	0.018721	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
890	N	N	N	N	Rocuronium bromide	CHRNA4: cholinergic receptor, nicotinic, alpha 4 (neuronal)	0.22368	Codeine sulfate	0.52847	CHRNA2
891	N	N	N	N	Trimipramine	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.60714	Profenamine hydrochloride	0.010907	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
892	N	N	N	N	Thioridazine	KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 9	0.34884	Verapamil	0.68294	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
893	N	N	N	N	Amiloride hydrochloride	GRID2: glutamate receptor, ionotropic, delta 2	0.26923	Riluzole	0.014175	MCOLN1: mucolipin 1
894	N	N	N	N	Gallopamil hydrochloride	KCNA2: potassium voltage-gated channel, shaker-related subfamily, member 2	0.86486	Verapamil	0.025006	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
895	N	N	N	N	Tubocurarine chloride	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta	0.23975	Midazolam	0.29568	GABRA5
896	N	N	N	N	Felbamate	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.45000	Benzocaine	0.010173	GLRA2: glycine receptor, alpha 2
897	N	N	N	N	Loratadine	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.32558	Diltiazem hydrochloride	0.55487	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
898	N	N	N	N	Caffeine	MCOLN1: mucolipin 1	0.14286	Amiloride hydrochloride	0.023510	P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1
899	N	N	N	N	Bupivacaine hydrochloride	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.41935	Tolazamide	0.39592	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
900	N	N	N	N	Kainic acid hydrate	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	0.33333	Proline	0.012768	GRIK4: glutamate receptor, ionotropic, kainate 4
901	N	N	N	N	Promethazine teoclate	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	0.40476	Caffeine and sodium benzoate	0.31077	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
902	N	N	N	N	Methyclothiazide	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.57143	Cyclothiazide	0.010212	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
903	N	N	N	N	Caffeine	TRPC6: transient receptor potential cation channel, subfamily C, member 6	0.14286	Amiloride hydrochloride	0.016201	P2RX5: purinergic receptor P2X, ligand-gated ion channel, 5
904	N	N	N	N	Diazoxide	P2RX3: purinergic receptor P2X, ligand-gated ion channel, 3	0.21739	Caffeine	0.030341	KCNE2: potassium voltage-gated channel, Isk-related family, member 2
905	N	N	N	N	Gallopamil hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.86486	Verapamil	0.11951	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
906	N	N	Y	N	Verapamil hydrochloride	CACNA1I: calcium channel, voltage-dependent, T type, alpha 1I subunit	0.97059	Verapamil	0.13350	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
907	N	N	N	N	Penicillin G procaine	GABRG3	0.38776	Flurazepam	0.40101	GABRA6
908	N	N	N	N	Procainamide hydrochloride	CHRND: cholinergic receptor, nicotinic, delta (muscle)	0.72727	Metoclopramide	0.012164	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
909	N	N	N	N	Aminoglutethimide	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.42105	Ethosuximide	0.0080876	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)
910	N	N	N	N	Diazoxide	P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6	0.21739	Caffeine	0.029220	KCNE3: potassium voltage-gated channel, Isk-related family, member 3
911	N	N	N	N	Amiodarone hydrochloride	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5	0.45000	Propafenone hydrochloride	0.51877	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
912	N	N	N	N	Halazepam	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.38461	Diltiazem hydrochloride	0.019068	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
913	N	N	N	N	Mepivacaine hydrochloride	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.75000	Bupivacaine hydrochloride	0.027135	KCNK5: potassium channel, subfamily K, member 5
914	N	N	N	N	Trichlormethiazide	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.36667	Furosemide	0.011447	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
915	N	N	N	N	Riluzole	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.26923	Amiloride hydrochloride	0.13386	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
916	N	N	N	N	Benzocaine	KCNK5: potassium channel, subfamily K, member 5	0.57895	Procaine hydrochloride	0.025338	SCN4B: sodium channel, voltage-gated, type IV, beta subunit
917	N	N	N	N	Azimilide dihydrochloride	KCNE1: potassium voltage-gated channel, Isk-related family, member 1	0.21818	Verapamil	0.026945	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1
918	N	N	N	N	Flurazepam	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.46154	Diltiazem hydrochloride	0.019626	GABRD: gamma-aminobutyric acid (GABA) A receptor, delta
919	N	N	N	N	Procainamide hydrochloride	CHRNB1: cholinergic receptor, nicotinic, beta 1 (muscle)	0.72727	Metoclopramide	0.013618	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
920	N	N	N	N	Fluoxetine hydrochloride	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1	0.46875	Halazepam	0.021675	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
921	N	N	N	N	Enoxacin hydrate	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.30682	Trifluoperazine maleate	0.021832	GABRA3
922	N	N	N	N	Codeine phosphate	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.16176	Exemestane	0.44784	CHRNA2
923	N	N	Y	N	Primidone	GABRA5	0.43478	Ketamine hydrochloride	0.69495	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
924	N	N	N	N	Enoxacin hydrate	GABRG3	0.22500	Flurazepam	0.40101	GABRA6
925	N	N	N	N	Quinine hydrochloride hydrate	KCNA10: potassium voltage-gated channel, shaker-related subfamily, member 10	0.31250	Ketoconazole	0.53242	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
926	N	N	N	N	Oxcarbazepine	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.53846	Desipramine hydrochloride	0.011391	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
927	N	N	N	N	Diazoxide	P2RX1: purinergic receptor P2X, ligand-gated ion channel, 1	0.21739	Caffeine	0.045455	KCNE3: potassium voltage-gated channel, Isk-related family, member 3
928	N	N	N	N	Amiodarone hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.42105	Fluoxetine	0.027535	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
929	N	N	N	N	Verapamil	GRIN2D: glutamate receptor, ionotropic, N-methyl D-aspartate 2D	0.28261	Haloperidol	0.029109	KCNK4: potassium channel, subfamily K, member 4
930	N	N	N	N	Mazindol	SLC6A7: solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	0.076923	Proline	0.41013	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
931	N	N	Y	Y	Clobazam	GABRA2	0.78261	Diazepam	0.74880	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
932	N	N	N	N	Ibutilide fumarate	KCNK5: potassium channel, subfamily K, member 5	0.29167	Verapamil	0.17161	KCNK1: potassium channel, subfamily K, member 1
933	N	N	N	N	Ethotoin	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.36000	Phenytoin	0.58238	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
934	N	N	N	N	Trifluoperazine hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.60526	Moricizine hydrochloride	0.0087397	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
935	N	N	N	N	Bepridil hydrochloride	KCNN3: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3	0.47059	Desipramine hydrochloride	0.035737	KCNQ4: potassium voltage-gated channel, KQT-like subfamily, member 4
936	N	N	N	N	Doxorubicin hydrochloride	SCN5A: sodium channel, voltage-gated, type V, alpha subunit	0.30508	Quinidine gluconate	0.0051579	RYR1: ryanodine receptor 1 (skeletal)
937	N	N	N	N	Diazoxide	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.29167	Ketamine hydrochloride	0.094588	GRIA2: glutamate receptor, ionotropic, AMPA 2
938	N	N	N	N	Phencyclidine hydrochloride	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.44444	Dextromethorphan	0.015803	CHRNA10
939	N	N	N	N	Propafenone hydrochloride	KCNK16: potassium channel, subfamily K, member 16	0.34091	Verapamil	0.24672	KCNK5: potassium channel, subfamily K, member 5
940	N	N	N	N	Indapamide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.43333	Glyclopyramide	0.029070	KCNE1: potassium voltage-gated channel, Isk-related family, member 1
941	N	N	N	N	Astemizole	KCNH6: potassium voltage-gated channel, subfamily H (eag-related), member 6	0.28846	Verapamil	0.50037	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2
942	N	N	N	N	Loratadine	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.56250	Clozapine	0.017228	KCNA5: potassium voltage-gated channel, shaker-related subfamily, member 5
943	N	N	N	Y	Cocaine	SCN2A: sodium channel, voltage-gated, type II, alpha subunit	0.33333	Procaine hydrochloride	0.60832	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
944	N	N	N	N	Gabapentin	ASIC1: acid-sensing (proton-gated) ion channel 1	0.034483	Amiloride hydrochloride	0.47336	ASIC3: acid-sensing (proton-gated) ion channel 3
945	N	N	N	N	Codeine	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.38889	Quinine hydrochloride hydrate	0.015233	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
946	N	N	N	N	Penicillin G procaine	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.40476	Procaine hydrochloride	0.011567	GABRA2
947	N	N	N	N	Pramoxine hydrochloride	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.42105	Cisapride	0.019783	KCNK5: potassium channel, subfamily K, member 5
948	N	N	N	N	Thioridazine	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.53333	Maprotiline	0.020826	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
949	N	N	N	N	Codeine	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.35294	Granisetron	0.26265	CHRNA10
950	N	N	N	Y	Tocainide	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.93333	Tocainide hydrochloride	0.58865	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
951	N	N	N	N	Ketoconazole	KCNN2: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	0.37500	Trifluoperazine hydrochloride	0.34677	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
952	N	N	N	N	Verapamil hydrochloride	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit	0.97059	Verapamil	0.10383	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
953	N	N	N	N	Cetiedil citrate	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.31707	Methylphenidate	0.022059	KCNN4: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
954	N	N	N	N	Quinine sulfate	CHRNA2	0.39744	Codeine sulfate	0.017256	KCNA3: potassium voltage-gated channel, shaker-related subfamily, member 3
955	Y	N	N	N	Glyburide	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.45652	Astemizole	0.015300	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
956	N	N	N	N	Dofetilide	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11	0.41270	Ibutilide fumarate	0.025318	KCNK2: potassium channel, subfamily K, member 2
957	N	N	N	N	Desflurane	GABRA3	1	Isoflurane	0.66731	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
958	N	N	N	N	Bupivacaine hydrochloride	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1	0.34146	Flecainide acetate	0.22153	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3
959	N	N	N	N	Verapamil hydrochloride	KCND3: potassium voltage-gated channel, Shal-related subfamily, member 3	0.97059	Verapamil	0.24349	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
960	N	N	N	N	Pramoxine hydrochloride	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.25714	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
961	N	N	N	N	Biperiden	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.34615	Nicotine	0.44784	CHRNA2
962	N	N	N	N	Hydrochlorothiazide	GRIA2: glutamate receptor, ionotropic, AMPA 2	0.64000	Cyclothiazide	0.010212	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1
963	N	N	N	N	Halazepam	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.41667	Bendroflumethiazide	0.011447	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
964	N	N	N	N	Amiloride hydrochloride	SCN3A: sodium channel, voltage-gated, type III, alpha subunit	0.36000	Lamotrigine	0.12915	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit
965	N	N	N	N	Tolbutamide	SCN10A: sodium channel, voltage-gated, type X, alpha subunit	0.45833	Lidocaine	0.010834	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
966	N	N	N	N	Pramoxine hydrochloride	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.30769	Benzocaine	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
967	N	N	N	N	Dibucaine	KCNH2: potassium voltage-gated channel, subfamily H (eag-related), member 2	0.40476	Halofantrine hydrochloride	0.0091581	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
968	N	N	N	N	Ethotoin	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.52381	Aminoglutethimide	0.0091480	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
969	N	N	N	N	Amiodarone hydrochloride	KCNA1: potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)	0.38298	Verapamil	0.59825	KCNA7: potassium voltage-gated channel, shaker-related subfamily, member 7
970	N	N	N	N	Quinine sulfate	SCN1A: sodium channel, voltage-gated, type I, alpha subunit	1	Quinidine sulfate	0.020008	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2
971	N	N	N	N	Galantamine hydrobromide	KCNB2: potassium voltage-gated channel, Shab-related subfamily, member 2	0.36111	Quinine hydrochloride hydrate	0.015233	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)
972	N	N	N	N	Pentobarbital	GLRA3	0.027027	Tropisetron hydrochloride	0.32591	GABRA2
973	N	N	N	N	Glyclopyramide	KCNMA1: potassium large conductance calcium-activated channel, subfamily M, alpha member 1	0.32000	Diazoxide	0.0097843	KCNJ11: potassium inwardly-rectifying channel, subfamily J, member 11
974	N	N	N	N	Dantrolene	KCNQ1: potassium voltage-gated channel, KQT-like subfamily, member 1	0.50000	Azimilide dihydrochloride	0.0059674	RYR1: ryanodine receptor 1 (skeletal)
975	N	N	N	N	Rocuronium bromide	CHRNA3: cholinergic receptor, nicotinic, alpha 3 (neuronal)	0.22368	Codeine sulfate	0.52424	CHRNA2
976	N	N	N	N	Verapamil	GRIN3B: glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	0.28261	Haloperidol	0.026014	KCNE1: potassium voltage-gated channel, Isk-related family, member 1
977	N	N	N	N	Zonisamide	GRIN3A: glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	0.29167	Felbamate	0.022827	SCN4B: sodium channel, voltage-gated, type IV, beta subunit
978	N	N	N	N	Carbamazepine	CACNA1G: calcium channel, voltage-dependent, T type, alpha 1G subunit	0.37037	Phenytoin	0.13386	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
979	N	N	N	N	Dizocilpine maleate	KCNJ9: potassium inwardly-rectifying channel, subfamily J, member 9	0.23404	Verapamil	0.68294	KCNJ6: potassium inwardly-rectifying channel, subfamily J, member 6
980	N	N	N	N	Dibucaine	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.17500	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
981	N	N	N	N	Caffeine	KCNK12: potassium channel, subfamily K, member 12	0	Halothane	0.019268	P2RX6: purinergic receptor P2X, ligand-gated ion channel, 6
982	N	N	N	N	Prilocaine	SCN8A: sodium channel, voltage gated, type VIII, alpha subunit	0.94118	Prilocaine hydrochloride	0.58865	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
983	N	N	N	N	Ketamine hydrochloride	GLRA1: glycine receptor, alpha 1	0.39286	Tropisetron hydrochloride	0.32784	GABRA2
984	N	N	N	Y	Benzocaine	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.57895	Procaine hydrochloride	0.75410	SCN3A: sodium channel, voltage-gated, type III, alpha subunit
985	N	N	N	N	Dextromethorphan	SLC6A1: solute carrier family 6 (neurotransmitter transporter, GABA), member 1	0.35484	Cocaine	0.41406	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
986	N	N	N	N	Gallopamil hydrochloride	CHRNA2	0.36508	Metocurine iodide	0.010362	CACNA1S: calcium channel, voltage-dependent, L type, alpha 1S subunit
987	N	N	N	N	Chloroprocaine hydrochloride	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.28125	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
988	N	N	N	N	Nateglinide	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.48387	Granisetron	0.017658	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
989	N	N	N	N	Primidone	CHRNB2: cholinergic receptor, nicotinic, beta 2 (neuronal)	0.57143	Aminoglutethimide	0.090264	GABRA1: gamma-aminobutyric acid (GABA) A receptor, alpha 1
990	N	N	N	N	Amiloride hydrochloride	SCN4A: sodium channel, voltage-gated, type IV, alpha subunit	0.36000	Lamotrigine	0.11479	CACNA1H: calcium channel, voltage-dependent, T type, alpha 1H subunit
991	N	N	N	N	Glimepiride	CFTR: cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49)	0.55814	Glyburide	0.014445	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1
992	N	N	N	N	Biperiden	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	0.36364	Cocaine	0.020712	CHRNA2
993	N	N	N	N	Benzocaine	SCN11A: sodium channel, voltage-gated, type XI, alpha subunit	0.36000	Cocaine	0.47691	SCN10A: sodium channel, voltage-gated, type X, alpha subunit
994	N	N	N	N	Maprotiline	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.51852	Mirtazapine	0.018814	SLC6A2: solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
995	N	N	N	N	Proparacaine hydrochloride	SCN7A: sodium channel, voltage-gated, type VII, alpha subunit	0.36000	Benzocaine	0.48453	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit
996	N	N	N	N	Kainic acid hydrate	CLCN2: chloride channel, voltage-sensitive 2	0.22857	Lubiprostone	0.012355	GRIK4: glutamate receptor, ionotropic, kainate 4
997	N	N	N	N	Prilocaine	KCNJ1: potassium inwardly-rectifying channel, subfamily J, member 1	0.47826	Tolbutamide	0.0099976	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
998	N	N	N	Y	Tocainide	SCN9A: sodium channel, voltage-gated, type IX, alpha subunit	0.93333	Tocainide hydrochloride	0.59648	SCN5A: sodium channel, voltage-gated, type V, alpha subunit
999	N	N	N	N	Gallopamil hydrochloride	KCNC1: potassium voltage-gated channel, Shaw-related subfamily, member 1	0.86486	Verapamil	0.025943	CACNA1C: calcium channel, voltage-dependent, L type, alpha 1C subunit
1000	N	N	N	N	Sertraline	HTR3A: 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic	0.53571	Clozapine	0.013198	SLC6A4: solute carrier family 6 (neurotransmitter transporter, serotonin), member 4